Other diseases of anus and rectum

K11_OTHANRECT

rectal disease: A disease that involves the rectum. [database_cross_reference: MONDO:patterns/location]

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K62 Hospital discharge: ICD-9 — 569[0-4] Hospital discharge: ICD-8 — 5690[6-7] Cause of death: ICD-10 — K62 Cause of death: ICD-9 — 569[0-4] Cause of death: ICD-8 — 5690[6-7] 2 out of 7 registries used, show all original rules.	14404
4. Check minimum number of events None	14404
5. Include endpoints None	14404
6. Filter based on genotype QC (FinnGen only)	14404

Control definitions (FinnGen only)

Control exclude: K11_INTESTOTH

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K55-K63
Name in latin: Alii morbi ani et recti

NAME	K11_OTHANRECT
CONTROL_EXCLUDE	K11_INTESTOTH
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K62
HD_ICD_9	569[0-4]
HD_ICD_8	5690[6-7]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K62
COD_ICD_9	569[0-4]
COD_ICD_8	5690[6-7]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other diseases of anus and rectum based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	104510	58332	45441
Only index persons	90795	51505	39290
Unadjusted period prevalence (%)
Whole population	1.49	1.67	1.27
Only index persons	1.72	1.89	1.50
Median age at first event (years)
Whole population	62.86	64.48	60.73
Only index persons	61.46	62.87	59.62

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	14404	7913	6491
Unadjusted period prevalence (%)	2.77	2.70	2.86
Median age at first event (years)	61.04	58.23	64.46

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
12814: Matched controls
128003

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R15

ICD-10 Finland

Faecal incontinence

9.9

323.0

699

744

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

149.0

323.0

6226

807

K62.0

ICD-10 Finland

Anal polyp

447.1

323.0

1298

K62.7

ICD-10 Finland

Radiation proctitis

305.6

323.0

525

JHA20

NOMESCO Finland

Excision of lesion of anal canal or perianal tissue

67.4

323.0

763

120

K92.1

ICD-10 Finland

Melaena

7.5

323.0

1395

2061

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

6.1

323.0

947

1647

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

28.9

323.0

3260

1492

JHB00

NOMESCO Finland

Hemorrhoidectomy

11.7

323.0

1062

981

UJF32

NOMESCO Finland

Coloscopy

12.2

323.0

6911

11172

K62.8

ICD-10 Finland

Other specified diseases of anus and rectum

189.1

323.0

915

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

211.4

323.0

410

K62.9

ICD-10 Finland

Disease of anus and rectum, unspecified

83.4

323.0

474

JGC01

NOMESCO Finland

Laparoscopic rectopexy

177.1

323.0

576

K59.09

ICD-10 Finland

Constipation, unspecified

8.7

323.0

894

1097

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.9

323.0

4934

22713

K62.3

ICD-10 Finland

Rectal prolapse

376.5

323.0

1601

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

6.9

323.0

979

1515

A02BC02

ATC

pantoprazole; systemic

2.2

323.0

8372

59740

K62.2

ICD-10 Finland

Anal prolapse

410.5

323.0

923

P01AB01

ATC

metronidazole; oral, rectal

2.2

323.0

4912

27945

C05AA08

ATC

fluocortolone; rectal, topical

4.3

323.0

2885

8141

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

8.9

323.0

738

877

UJF30

NOMESCO Finland

Ileoscopy through colon

7.5

323.0

1903

2898

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

9.6

323.0

2325

2901

K60.1

ICD-10 Finland

Chronic anal fissure

77.0

323.0

595

6453

FHL

Radical surgery of hemorrhoids

240.9

323.0

352

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

10.2

323.0

723

746

UJH02

NOMESCO Finland

Anoscopy

20.2

323.0

1710

967

A07EC02

ATC

mesalazine; oral, rectal

6.3

323.0

1209

2067

K62.4

ICD-10 Finland

Stenosis of anus and rectum

3183.5

323.0

321

K62.6

ICD-10 Finland

Ulcer of anus and rectum

56.8

323.0

639

118

K62.1

ICD-10 Finland

Rectal polyp

353.7

323.0

1150

A06AC01

ATC

ispaghula (psylla seeds); oral

4.1

323.0

4317

14103

45599

ICD-8 Finland

Haemorrhoids

+∞

323.0

351

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

13.9

323.0

3047

2802

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

8.5

323.0

1365

1764

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

17.1

323.0

2300

1618

UJG02

NOMESCO Finland

Proctoscopy

17.3

323.0

810

498

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.3

323.0

4695

18867

K60.3

ICD-10 Finland

Anal fistula

254.5

315.4

323

K59.0

ICD-10 Finland

Constipation

6.7

311.8

843

1331

A06AD11

ATC

lactulose; oral

2.8

307.4

2304

9281

N02AX02

ATC

tramadol; systemic, rectal

2.0

299.4

5554

34886

A07EA02

ATC

hydrocortisone; rectal

9.8

299.2

630

669

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.6

298.1

2579

11290

I84.5

ICD-10 Finland

External hemorrhoids without complication

7.0

277.2

721

1075

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

6.0

273.0

798

1392

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

7.3

272.2

687

980

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.4

269.3

1444

4585

J01MA02

ATC

ciprofloxacin; systemic

2.0

268.6

5092

31831

K59.01

ICD-10 Finland

Constipation outlet obstruction type

231.2

264.1

272

5690A

ICD-9 Finland

Other disorders of intestine, Anal and rectal polyp

+∞

262.2

251

K60.2

ICD-10 Finland

Anal fissure, unspecified

23.1

258.8

380

169

N02BE01

ATC

paracetamol; systemic, rectal

2.2

257.7

10817

90688

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

5.2

240.2

797

1613

JHD00

NOMESCO Finland

Anal dilatation

62.6

240.0

282

J01DB01

ATC

cefalexin; oral

2.0

231.5

9983

81923

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

577.6

230.2

228

D16

ICPC

Rectal bleeding

8.2

228.7

535

677

A02BC05

ATC

esomeprazole; systemic

1.9

225.5

4956

32100

JHA00

NOMESCO Finland

Anal or perianal incision

49.9

224.6

274

N03AX16

ATC

pregabalin; oral

2.1

218.4

3026

16355

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

218.3

5511

37317

N81.6

ICD-10 Finland

Rectocele

3.6

214.4

1045

3051

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

11.5

212.4

411

369

UKC02

NOMESCO Finland

Cystoscopy

2.3

210.0

2284

11034

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

209.9

3440

19858

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

205.9

3387

19553

H02AB06

ATC

prednisolone; systemic

1.8

204.2

5788

40399

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

5.3

203.4

658

1289

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

200.2

2083

9824

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

6.3

199.9

563

930

JG1JB

NOMESCO Finland

Defekography with X-ray

29.5

190.9

261

I84

ICD-10 Finland

Hemorrhoids

5.9

189.7

559

978

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

26.7

186.5

262

100

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

8.9

185.8

411

473

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

183.9

2669

14551

JN3AD

NOMESCO Finland

Abdominal CT examination

3.3

179.9

973

3069

K61.0

ICD-10 Finland

Anal abscess

49.2

178.4

218

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.3

175.4

1941

9373

A06AC51

ATC

ispaghula, combinations; systemic

4.1

175.4

727

1835

A02BC03

ATC

lansoprazole; oral

1.8

173.0

3612

22463

K59.1

ICD-10 Finland

Functional diarrhoea

4.8

171.3

613

1338

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.8

169.1

596

1280

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

167.7

2612

14570

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

52.2

166.3

201

A02BC01

ATC

omeprazole; systemic

1.8

165.6

3423

21155

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

9.3

164.5

354

388

K56.7

ICD-10 Finland

Ileus, unspecified

126.5

162.5

175

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

4.8

162.4

580

1263

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.0

158.8

1007

3545

M79.6

ICD-10 Finland

Pain in limb

1.7

158.2

4151

27613

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

17.0

157.6

256

153

6451

FHL

Dilatation

206.0

157.2

163

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.6

156.5

1296

5370

JHD20

NOMESCO Finland

Incision of fistula-in-ano

766.6

154.6

152

JHD10

NOMESCO Finland

Myotomy of anal sphincter

162.8

152.7

161

N06AX11

ATC

mirtazapine; oral

1.8

152.7

3717

24098

C05AA01

ATC

hydrocortisone; rectal, topical

3.3

152.6

825

2592

XJH00

NOMESCO Finland

Transanal ultrasonography

2.9

151.2

1001

3620

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

149.3

1688

8182

M54.5

ICD-10 Finland

Low back pain

1.8

149.0

3683

23954

D64.9

ICD-10 Finland

Anaemia, unspecified

2.4

145.6

1380

6133

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

143.3

1453

6678

R06.0

ICD-10 Finland

Dyspnoea

1.8

142.8

2989

18384

A02BA02

ATC

ranitidine; systemic

1.9

142.0

2462

14180

WX002

NOMESCO Finland

Sedation and analgesia

1.9

141.8

2446

14062

5691A

ICD-9 Finland

Other disorders of intestine, Rectal prolapse

+∞

141.8

136

B01AB05

ATC

enoxaparin; parenteral

1.7

141.4

3690

24310

K64.2

ICD-10 Finland

Third degree haemorrhoids

22.3

140.1

207

J01MA12

ATC

levofloxacin; systemic

1.9

140.0

2282

12841

R53

ICD-10 Finland

Malaise and fatigue

1.9

139.4

2472

14341

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

139.4

1620

7932

K56.1

ICD-10 Finland

Intussusception

1362.3

137.7

134

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

137.3

5241

38324

D01

ICPC

Abdominal pain/cramps general

2.5

136.7

1151

4797

I84.4

ICD-10 Finland

External hemorrhoids with other complications

8.7

136.2

305

358

JHB40

NOMESCO Finland

Resection and stapled suture of anal mucosa

94.8

135.2

150

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

135.0

4024

27471

A07EA06

ATC

budesonide; oral, local oral

4.6

133.9

491

1096

UJF92

NOMESCO Finland

Capsular endoscopy

7.3

133.6

336

473

JHB96

NOMESCO Finland

Other procedure for haemorrhoids or prolapse of mucosa

24.3

132.1

190

N03AX12

ATC

gabapentin; oral

2.0

131.9

1840

9722

R51.80

ICD-10 Finland

Headache

2.1

131.7

1618

8103

K64.1

ICD-10 Finland

Second degree haemorrhoids

12.2

131.3

245

204

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.5

130.6

1145

4869

WX110

NOMESCO Finland

Local anesthesy

1.6

129.6

7777

63312

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.7

128.2

951

3680

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

6.9

127.4

330

485

K51.5

ICD-10 Finland

Left sided colitis

5.0

127.2

427

868

XKD00

NOMESCO Finland

Uroflowmetry

1.9

127.0

2025

11255

K60.0

ICD-10 Finland

Acute anal fissure

20.6

124.7

189

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.7

124.7

589

1659

5650B

ICD-9 Finland

Anal fissure and fistula, Anal fissure[FISSURA ANI TYPICA]

+∞

124.1

119

N05CF01

ATC

zopiclone; oral

1.6

123.8

3884

26748

JG1JG

NOMESCO Finland

MRI of rectal function (MR defecography)

39.7

123.4

157

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

46.5

123.3

152

R03AC02

ATC

salbutamol; inhalant

1.6

122.0

5877

45073

4550A

ICD-9 Finland

Haemorrhoids, Internal haemorrhoids without mention of complication

+∞

122.0

117

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

4.8

120.6

422

897

SPAT1263

SPAT

Sampling

1.6

120.4

4961

36589

N06AX21

ATC

duloxetine; oral

2.3

118.2

1202

5502

J01AA02

ATC

doxycycline; systemic

1.6

116.9

9171

78564

UJD02

NOMESCO Finland

Gastroscopy

3.1

116.1

674

2220

S18

ICPC

Laceration/cut

1.6

116.0

4840

35705

N05BA04

ATC

oxazepam; oral

1.7

115.9

2858

18306

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.5

115.9

971

4022

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

115.4

1470

7446

4556A

ICD-9 Finland

Haemorrhoids, Unspecified haemorrhoids without mention of complication

+∞

113.6

109

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

113.1

4064

28838

K63.5

ICD-10 Finland

Polyp of colon

20.5

112.1

170

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

111.6

2362

14411

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

110.9

3731

25994

K30

ICD-10 Finland

Functional dyspepsia

2.3

109.7

1167

5448

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

16.5

109.2

179

110

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.0

108.3

1598

8578

R42

ICD-10 Finland

Dizziness and giddiness

1.7

107.7

2563

16189

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

107.5

1712

9454

K56.0

ICD-10 Finland

Paralytic ileus

1056.1

107.5

105

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

107.0

2027

11904

J02AC01

ATC

fluconazole; systemic

1.6

104.0

4153

30086

M25.5

ICD-10 Finland

Pain in joint

1.6

103.9

3027

20229

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

103.7

1255

6203

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

103.7

4276

31210

AA1AD

NOMESCO Finland

CT of head and brain

1.7

103.6

2827

18550

D04

ICPC

Rectal/anal pain

7.2

103.4

261

370

56500

ICD-8 Finland

Anal fissure and fistula, Anal fissure

+∞

103.2

J01DA01

ATC

[U] cefalexin; systemic

1.5

103.2

7200

59076

C61

ICD-10 Finland

Malignant neoplasm of prostate

2.1

102.8

1315

6656

K96

ICPC

Haemorrhoids

4.6

101.7

373

832

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

2.1

100.8

1268

6367

C03CA01

ATC

furosemide; systemic

1.6

100.5

3607

25409

M03BX02

ATC

tizanidine; oral

1.5

100.3

6635

53667

N06AB04

ATC

citalopram; systemic

1.7

99.6

2397

15147

C07AB07

ATC

bisoprolol; oral

1.5

98.6

5629

44056

A03CA02

ATC

clidinium and psycholeptics; oral

2.6

98.2

750

2939

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

98.1

1920

11364

L04AX01

ATC

azathioprine; systemic

3.1

97.7

564

1847

J01CA04

ATC

amoxicillin; systemic

1.5

97.4

9246

80555

L03

ICPC

Low back symptom/complaint

1.7

97.0

2581

16771

1470

FHL

Rectoscopy

25.6

96.9

137

6459

FHL

Other measure in this category

42.0

96.4

121

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.4

96.0

501

1525

K64.0

ICD-10 Finland

First degree haemorrhoids

10.1

95.7

196

197

N30.0

ICD-10 Finland

Acute cystitis

1.9

95.4

1602

8990

G04CA02

ATC

tamsulosin; oral

1.7

95.3

2620

17168

JGC00

NOMESCO Finland

Rectopexy

+∞

93.8

116

Kela drug reimbursment

Prostate cancer

2.4

93.3

851

3673

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

914.0

92.9

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

5.2

92.6

300

586

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

92.3

1104

5416

K55.2

ICD-10 Finland

Angiodysplasia of colon

314.7

91.9

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

91.6

5442

42708

N02AA05

ATC

oxycodone; systemic

1.8

91.1

1735

10154

R19.5

ICD-10 Finland

Other faecal abnormalities

6.9

91.0

236

348

E0000UV

ATC

1.5

90.9

4305

32175

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

90.5

4345

32563

K57.1

ICD-10 Finland

Diverticular disease of small intestine without perforation or abscess

23.0

90.5

132

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

3.1

90.0

531

1766

R31

ICD-10 Finland

Unspecified haematuria

2.0

89.8

1233

6403

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

89.5

1966

12039

WX320

NOMESCO Finland

Spinalanesthesy

1.6

89.5

2604

17285

K59.4

ICD-10 Finland

Anal spasm

53.8

89.4

107

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.0

89.3

539

1821

R11

ICD-10 Finland

Nausea and vomiting

2.3

88.8

889

4016

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

88.2

3266

23031

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

88.1

4636

35378

N06AA09

ATC

amitriptyline; systemic

2.1

88.0

1155

5887

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.2

87.6

982

4675

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

87.6

1930

11819

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.6

87.4

2451

16092

N06AX16

ATC

venlafaxine; oral

1.9

87.3

1384

7590

D06

ICPC

Abdominal pain localized other

2.4

87.1

813

3545

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

86.6

1279

6829

J01FF01

ATC

clindamycin; systemic

1.6

86.4

2951

20380

R50.9

ICD-10 Finland

Fever, unspecified

1.8

86.3

1555

8919

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

86.0

2536

16869

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

85.0

1183

6169

K50.9

ICD-10 Finland

Crohn disease, unspecified

7.0

84.3

216

313

G44.2

ICD-10 Finland

Tension-type headache

1.9

84.0

1335

7323

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

9.4

83.4

177

190

J01EA01

ATC

trimethoprim; systemic

1.6

83.4

2879

19910

D18

ICPC

Change in faeces/bowel movements

4.6

83.1

304

677

M01AH05

ATC

etoricoxib; oral

1.4

82.8

6210

50657

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

812.7

82.5

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

14.4

81.7

141

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

81.6

2273

14859

A03FA02

ATC

cisapride; oral, rectal

2.2

81.2

925

4433

D11

ICPC

Diarrhoea

2.0

80.9

1073

5482

I84.8

ICD-10 Finland

Unspecified hemorrhoids with other complications

11.3

80.9

156

140

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

80.6

1661

9939

N06AB10

ATC

escitalopram; oral

1.7

80.2

1957

12322

R33

ICD-10 Finland

Retention of urine

2.1

80.1

961

4710

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

9.4

79.8

169

181

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

79.6

7500

63666

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

79.6

3362

24327

L02AE02

ATC

leuprorelin; implant, parenteral

2.5

79.6

662

2717

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

4.4

79.4

302

699

R07.3

ICD-10 Finland

Other chest pain

2.0

78.6

1050

5380

WX402

NOMESCO Finland

General anaesthesia

1.7

77.6

1711

10445

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

4.5

77.6

285

637

R01AD09

ATC

mometasone; nasal

1.4

77.3

4572

35453

JAH00

NOMESCO Finland

Laparotomy

4.4

77.2

296

691

H02AB07

ATC

prednisone; oral

1.8

77.0

1625

9788

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

3.7

76.8

351

960

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

76.4

1948

12404

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

76.4

1895

11973

R52.9

ICD-10 Finland

Pain, unspecified

2.1

75.8

919

4522

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

75.7

2885

20348

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

75.6

2412

16297

K57

ICD-10 Finland

Diverticular disease of intestine

6.8

75.5

196

290

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

75.4

5780

47009

A04

ICPC

Weakness/tiredness general

1.8

75.4

1448

8460

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

74.6

1164

6324

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

74.2

1027

5331

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

9.1

73.3

158

175

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

73.2

4201

32285

ZX120

NOMESCO Finland

Intravenous

2.0

73.1

1070

5676

R01AD08

ATC

fluticasone; nasal

1.5

72.8

2876

20422

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

72.6

4980

39576

R35

ICD-10 Finland

Polyuria

2.3

72.6

720

3231

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

72.1

874

4295

L28

ICPC

Limited function/disability (L)

1.7

71.9

1813

11489

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

71.6

1771

11163

R06AE07

ATC

cetirizine; oral

1.4

71.2

4508

35251

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

70.7

1559

9496

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

70.6

1752

11046

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

70.2

735

3382

N05AH04

ATC

quetiapine; oral

1.7

70.1

1623

10031

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

69.4

2844

20323

A28

ICPC

Limited function/disability NOS

1.7

69.4

1771

11249

C10AC01

ATC

colestyramine; oral

3.9

69.4

299

778

XF402

NOMESCO Finland

ECG with work load test

1.8

69.1

1268

7283

N81.5

ICD-10 Finland

Vaginal enterocele

4.1

69.1

281

694

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

68.3

1140

6338

D12

ICPC

Constipation

3.2

68.3

377

1196

K50.8

ICD-10 Finland

Other Crohn disease

6.1

68.2

193

321

G47.3

ICD-10 Finland

Sleep apnoea

1.6

67.7

2083

13896

J01FA10

ATC

azithromycin; systemic

1.4

67.6

5955

49268

N05BA01

ATC

diazepam; systemic, rectal

1.7

67.1

1457

8822

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

66.9

2472

17235

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

66.7

6658

56220

M79.1

ICD-10 Finland

Myalgia

1.8

66.7

1271

7388

M01AE02

ATC

naproxen; oral, rectal

1.4

66.6

6003

49813

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

66.4

771

3717

A01

ICPC

Pain general/multiple sites

2.1

66.4

841

4209

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

66.2

922

4793

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

66.1

2692

19178

L17

ICPC

Foot/toe symptom/complaint

1.5

66.0

2658

18887

JFB00

NOMESCO Finland

Partial resection of small intestine

6.6

66.0

176

271

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

65.6

2643

18776

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

65.5

5450

44557

M02AA07

ATC

piroxicam; topical

1.4

65.4

4042

31322

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

15.4

65.3

109

Z01.2

ICD-10 Finland

Dental examination

1.4

65.2

4130

32149

M01AB05

ATC

diclofenac; systemic, rectal

1.4

65.1

7248

62228

5692A

ICD-9 Finland

Other disorders of intestine, Stenosis of rectum and anus

+∞

64.6

4553A

ICD-9 Finland

Haemorrhoids, External haemorrhoids without mention of complication

+∞

64.6

JFB46

NOMESCO Finland

Resection of sigmoid colon

7.6

64.6

155

205

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

64.5

1659

10543

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

64.5

2239

15366

WZC30

NOMESCO Finland

Teaching

1.7

64.5

1431

8717

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.1

64.4

806

4007

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

64.1

3393

25497

G04BD08

ATC

solifenacin; oral

2.1

63.8

780

3843

SPAT1153

SPAT

Removal of sutures

1.4

63.4

3495

26469

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

3.7

63.4

294

815

K50.1

ICD-10 Finland

Crohn disease of large intestine

6.5

63.3

170

264

M48.0

ICD-10 Finland

Spinal stenosis

1.7

63.2

1339

8038

SPAT1254

SPAT

Administration of medicine

1.6

63.1

1652

10547

K51.8

ICD-10 Finland

Other ulcerative colitis

5.5

63.1

194

358

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

63.0

2792

20224

R05

ICD-10 Finland

Cough

1.6

62.9

2013

13534

R13

ICD-10 Finland

Dysphagia

2.2

62.8

710

3382

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

62.7

2685

19303

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

27.9

62.6

R10.0

ICD-10 Finland

Acute abdomen

3.4

62.5

315

933

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

62.4

1409

8622

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

4.0

62.3

258

648

Z71.8

ICD-10 Finland

Other specified counselling

1.5

62.2

2373

16624

R4110

NOMESCO Finland

Physiotherapy

1.5

61.9

2817

20507

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

61.8

2382

16723

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

61.7

6700

57036

UJF34

NOMESCO Finland

Left colonoscopy

8.9

61.6

134

151

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

61.6

1430

8817

N03AE01

ATC

clonazepam; systemic

2.2

61.4

633

2889

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

61.2

4628

37065

K52.0

ICD-10 Finland

Gastroenteritis and colitis due to radiation

16.6

61.1

K56.2

ICD-10 Finland

Volvulus

600.3

60.8

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

60.7

3856

29935

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.3

60.6

320

983

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

6.2

60.4

168

274

G04BD12

ATC

mirabegron; oral

1.8

60.2

1121

6454

N06AB03

ATC

fluoxetine; oral

1.7

60.1

1261

7543

N05CF02

ATC

zolpidem; oral

1.6

59.6

1765

11625

SPAT1301

SPAT

No procedures

1.4

59.6

3510

26847

5621A

ICD-9 Finland

Diverticula of intestine, Colon[DIVERTICULOSIS COLI]

+∞

59.4

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

59.4

1882

12607

N06AB06

ATC

sertraline; oral

1.8

59.3

1031

5801

JN4BD

NOMESCO Finland

Extensive body CT

1.8

59.1

1196

7072

J01FA06

ATC

roxithromycin; oral

1.4

59.0

4285

34021

XJH10

NOMESCO Finland

Anorectal manometry

18.7

58.6

K55.8

ICD-10 Finland

Other vascular disorders of intestine

298.2

58.3

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

57.7

2010

13763

C01DA14

ATC

isosorbide mononitrate; oral

1.6

57.4

1845

12388

R60.0

ICD-10 Finland

Localized oedema

1.7

57.4

1208

7224

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

7.7

57.3

136

177

I84.0

ICD-10 Finland

Internal thrombosed hemorrhoids

8.0

56.7

132

167

SPAT1262

SPAT

Handing over of treatment supplies

1.5

56.4

1991

13668

JF2BD

NOMESCO Finland

Extensive colon CT

7.9

55.7

130

165

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

4.6

55.6

200

439

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

6.4

55.6

151

239

SPAT1312

SPAT

General health counselling

1.4

55.4

3365

25810

J01MA06

ATC

norfloxacin; oral

1.6

55.1

1440

9164

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

55.0

1047

6068

WX892

NOMESCO Finland

Monitored bed care

1.9

54.9

829

4431

K50.0

ICD-10 Finland

Crohn disease of small intestine

5.6

54.9

166

301

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

54.9

904

4988

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

54.7

2882

21519

D17

ICPC

Incontinence of bowel

6.8

54.5

141

209

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

54.5

1154

6913

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

54.4

10175

93627

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.3

54.4

525

2319

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.8

54.2

371

1358

56907

ICD-8 Finland

Other diseases of intestines and peritoneum, Prolapsus recti

+∞

54.2

J01MA01

ATC

ofloxacin; systemic

1.8

54.1

959

5424

B01AA03

ATC

warfarin; systemic

1.5

54.0

2350

16875

JGA28

NOMESCO Finland

Endoscopic contact coagulation in rectum

76.6

53.9

C07AA05

ATC

propranolol; systemic

1.5

53.7

1845

12570

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

5.2

53.5

172

335

J01CA08

ATC

pivmecillinam; oral

1.4

53.4

4105

32753

D07AC01

ATC

betamethasone; topical

1.4

53.4

3549

27622

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

53.2

779

4116

5621B

ICD-9 Finland

Diverticula of intestine, Colon[DIVERTICULITIS COLI SINE HAEMORRHAGIA]

+∞

53.1

WW500

NOMESCO Finland

Blood transfusion

2.4

53.0

460

1928

TKC20

NOMESCO Finland

Catheterisation of bladder

1.9

52.9

803

4299

JAH01

NOMESCO Finland

Laparoscopy

2.5

52.8

426

1717

JGA52

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in rectum

114.4

52.8

K64.8

ICD-10 Finland

Other specified haemorrhoids

13.6

52.5

R52.2

ICD-10 Finland

Other chronic pain

2.8

52.5

355

1289

K02.1

ICD-10 Finland

Caries of dentine

1.3

52.2

5687

47894

JHC60

NOMESCO Finland

Transanal submucous or intersphincteric injection

+∞

52.1

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

3.9

51.9

224

585

C08CA01

ATC

amlodipine; oral

1.4

51.6

3959

31532

M01AX17

ATC

nimesulide; oral

1.4

51.3

2597

19198

R10.2

ICD-10 Finland

Pelvic and perineal pain

3.6

51.1

240

673

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.0

51.1

699

3597

A02BC04

ATC

rabeprazole; oral

1.9

51.0

803

4354

N05BA12

ATC

alprazolam; oral

1.8

50.9

1022

6014

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

50.8

1138

6926

K57.0

ICD-10 Finland

Diverticular disease of small intestine with perforation and abscess

135.4

50.8

M01AH01

ATC

celecoxib; oral (coxibs)

1.5

50.8

1866

12895

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

50.7

1894

13138

Z00.0

ICD-10 Finland

General medical examination

1.5

50.5

1924

13403

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

49.9

4185

33775

K29.7

ICD-10 Finland

Gastritis, unspecified

2.6

49.9

377

1465

N05CD07

ATC

temazepam; oral

1.6

49.8

1384

8934

I84.6

ICD-10 Finland

Residual hemorrhoidal skin tags

9.8

49.5

102

105

L02BB03

ATC

bicalutamide; oral

2.6

49.5

384

1513

SPAT1255

SPAT

Intravenous administration of medicine

2.0

49.4

705

3687

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

49.3

855

4796

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

49.3

1738

11891

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

49.1

1550

10328

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

48.9

1194

7442

K61.1

ICD-10 Finland

Rectal abscess

130.3

48.8

B02AA02

ATC

tranexamic acid; systemic

1.6

48.6

1399

9110

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

4.0

48.5

202

512

K64.3

ICD-10 Finland

Fourth degree haemorrhoids

16.7

48.4

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

48.3

5712

48480

L08

ICPC

Shoulder symptom/complaint

1.5

48.2

1874

13099

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

47.8

710

3772

N81.1

ICD-10 Finland

Cystocele

1.9

47.4

695

3672

R01AD12

ATC

fluticasone furoate; nasal

1.4

47.3

2673

20128

U02

ICPC

Urinary frequency/urgency

1.6

47.3

1309

8436

SPAT1240

SPAT

Therapeutic discussion

1.8

47.2

921

5367

SPAT1229

SPAT

Assessment of need for aid

1.8

47.1

890

5137

M54.6

ICD-10 Finland

Pain in thoracic spine

2.0

47.1

628

3201

H02AB04

ATC

methylprednisolone; systemic

1.6

47.0

1468

9750

Y77

ICPC

Malignant neoplasm prostate

2.5

47.0

376

1509

L01

ICPC

Neck symptom/complaint

1.6

46.9

1285

8257

N40

ICD-10 Finland

Hyperplasia of prostate

1.5

46.8

2203

16015

A98

ICPC

Health maint/preventive medicine

1.5

46.6

11381

107682

M79.7

ICD-10 Finland

Fibromyalgia

2.8

46.6

314

1140

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

46.6

2325

17097

E000001

ATC

1.5

46.4

2061

14806

A07DA03

ATC

loperamide; oral

2.4

46.2

400

1673

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.2

46.0

504

2363

M01AH02

ATC

rofecoxib; oral

1.6

45.9

1388

9144

JGC30

NOMESCO Finland

Excision and suture of rectal mucosa with imbrication of muscular layer

160.4

45.8

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

45.6

827

4705

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

45.1

1176

7457

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.2

45.0

460

2090

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

44.8

2302

17007

J20

ICD-10 Finland

Acute bronchitis

1.7

44.7

928

5510

K63.9

ICD-10 Finland

Disease of intestine, unspecified

20.4

44.7

J01FA09

ATC

clarithromycin; systemic

1.4

44.6

3059

23789

R02

ICPC

Shortness of breath/dyspnoea

1.6

44.5

1206

7719

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

44.4

1467

9869

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

44.3

2717

20723

6452

FHL

Sphincterotomy

438.7

44.2

6512

FHL

The path of laparatomy

438.7

44.2

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

44.1

557

2775

K92.0

ICD-10 Finland

Haematemesis

2.8

43.9

287

1022

ZXA00

NOMESCO Finland

Right side

1.4

43.9

2915

22536

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.5

43.9

1805

12746

R03DC03

ATC

montelukast; oral

1.5

43.6

1474

9965

XF404

NOMESCO Finland

Ambulatory ECG

1.7

43.6

983

5981

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

43.2

590

3033

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

43.1

654

3497

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

19.8

42.9

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

42.9

926

5564

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.0

42.8

606

3159

JFF10

NOMESCO Finland

Loop enterostomy

9.8

42.5

M54.2

ICD-10 Finland

Cervicalgia

1.9

42.5

653

3506

SPAT1216

SPAT

Assessment of functional ability

1.5

42.5

1667

11648

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

12.5

42.4

WZA90

NOMESCO Finland

Other doctors statement

1.4

42.3

2196

16232

N03AX09

ATC

lamotrigine; oral

2.3

42.1

410

1822

SPAT1310

SPAT

Counselling related to known health issue

1.3

42.0

3328

26444

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

42.0

466

2199

1471

FHL

Rectoscopy and polyp removal

68.6

42.0

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

41.8

835

4897

G04CA01

ATC

alfuzosin; oral

1.6

41.7

1157

7447

A07AA02

ATC

nystatin; oral

1.9

41.7

647

3489

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

41.7

4310

35631

56906

ICD-8 Finland

Other diseases of intestines and peritoneum, Prolapsus ani

+∞

41.7

K59.8

ICD-10 Finland

Other specified functional intestinal disorders

15.4

41.6

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

14.3

41.5

R21

ICPC

Throat symptom/complaint

1.5

41.4

1665

11690

XKC03

NOMESCO Finland

Water cystometry

2.5

41.2

339

1382

N39.3

ICD-10 Finland

Stress incontinence

1.8

41.1

701

3903

A46

ICD-10 Finland

Erysipelas

1.5

41.1

1450

9891

TJF80

NOMESCO Finland

Ostomy education

5.1

41.0

134

267

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.7

41.0

288

1073

R05

ICPC

Cough

1.4

40.9

2156

15969

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

3.9

40.8

173

446

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.4

40.8

358

1509

SPAT1260

SPAT

Consultation of another employee

1.5

40.7

1818

13040

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.8

40.7

747

4264

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

40.6

606

3221

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

40.3

569

2960

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

9.5

40.3

S29

ICPC

Skin symptom/complaint other

1.5

40.1

1680

11887

K60.4

ICD-10 Finland

Rectal fistula

398.3

40.1

R74

ICPC

Upper respiratory infection acute

1.4

40.1

2424

18395

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.8

40.1

703

3953

JGB96

NOMESCO Finland

Other proctectomy or excision of rectum

65.8

40.0

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

40.0

1387

9424

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

40.0

1554

10828

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

39.9

1091

6994

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

39.9

685

3826

K55.9

ICD-10 Finland

Vascular disorder of intestine, unspecified

75.3

39.9

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.1

39.8

475

2311

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.2

39.7

418

1926

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

39.7

2128

15801

D94

ICPC

Chronic enteritis/ulcerative colitis

7.6

39.6

124

B82

ICPC

Anaemia other/unspecified

2.8

39.5

265

959

X58

ICD-10 Finland

Exposure to other specified factors

1.6

39.4

1260

8396

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

5.3

39.4

123

233

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

39.4

998

6267

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

6.3

39.4

107

171

Z93.3

ICD-10 Finland

Colostomy status

6.3

39.4

107

171

JHA10

NOMESCO Finland

Biopsy of anal canal

23.4

39.1

JFF23

NOMESCO Finland

Transversostomy

4.7

38.9

136

292

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

38.9

2415

18399

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.7

38.7

283

1081

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

38.6

1035

6597

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.7

38.6

899

5515

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

38.6

1399

9594

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

38.4

752

4381

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

38.4

564

2978

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

38.3

1045

6688

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

38.3

2951

23278

JGC96

NOMESCO Finland

Other reconstructive operation on rectum

56.3

38.2

K64.4

ICD-10 Finland

Residual haemorrhoidal skin tags

18.5

38.2

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.8

38.2

728

4205

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

2.8

38.1

255

923

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

38.0

773

4557

R05FB02

ATC

cough suppressants and expectorants

1.3

38.0

3983

32870

N01

ICPC

Headache

1.7

38.0

844

5109

A01AB09

ATC

miconazole; local oral

1.7

37.8

867

5297

R04.0

ICD-10 Finland

Epistaxis

1.7

37.8

753

4413

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.7

37.8

896

5524

L13

ICPC

Hip symptom/complaint

1.5

37.7

1561

11009

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.7

37.7

751

4400

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

37.6

634

3517

D07AC13

ATC

mometasone; topical

1.3

37.5

2863

22541

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

37.5

655

3677

4559X

ICD-9 Finland

Haemorrhoids, Residual haemorrhoidal skin tags

+∞

37.5

5694X

ICD-9 Finland

Other disorders of intestine, Other specified disorders of rectum and anus

+∞

37.5

A11

ICPC

Chest pain NOS

1.8

37.4

729

4241

G04BD07

ATC

tolterodine; oral

1.9

37.4

560

2979

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

3.2

37.4

204

645

R03BA05

ATC

fluticasone; inhalant

1.4

37.1

1708

12300

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.7

37.0

751

4423

KMAK

NOMESCO Finland

1.3

37.0

5116

43770

R07.0

ICD-10 Finland

Pain in throat

1.9

36.8

527

2760

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.3

36.8

344

1499

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

36.7

4316

36136

R00.2

ICD-10 Finland

Palpitations

1.8

36.7

639

3584

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

9.3

36.7

U05

ICPC

Urination problems other

2.0

36.6

461

2293

JN4AD

NOMESCO Finland

Body CT examination

1.7

36.6

747

4406

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

49.0

36.5

J05AB01

ATC

aciclovir; systemic

1.4

36.5

2032

15166

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

36.4

705

4091

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

36.3

683

3929

-1

NOMESCO Finland

1.3

36.1

3146

25243

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

36.1

685

3950

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.4

36.0

307

1277

G04BD04

ATC

oxybutynin; oral, transdermal

1.9

36.0

576

3141

M54.3

ICD-10 Finland

Sciatica

1.9

35.8

547

2929

D07AD01

ATC

clobetasol; topical

1.5

35.8

1489

10503

G43.9

ICD-10 Finland

Migraine, unspecified

2.1

35.8

442

2183

M54

ICD-10 Finland

Dorsalgia

1.6

35.8

998

6421

C07AB02

ATC

metoprolol; systemic

1.4

35.8

2304

17626

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

35.7

1301

8922

L12

ICPC

Hand/finger symptom/complaint

1.5

35.6

1318

9072

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.7

35.6

731

4323

N17

ICPC

Vertigo/dizziness

1.6

35.5

1098

7249

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.2

35.4

389

1828

R32

ICD-10 Finland

Unspecified urinary incontinence

2.5

35.3

296

1220

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.6

35.2

265

1031

R20.2

ICD-10 Finland

Paraesthesia of skin

1.9

35.0

576

3170

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

35.0

7259

65098

U07

ICPC

Urine symptom/complaint other

1.9

34.9

569

3121

J01MA14

ATC

moxifloxacin; systemic

1.7

34.9

850

5278

SPAT1097

SPAT

Recording of ECG

1.5

34.9

1538

10974

N04BC05

ATC

pramipexole; oral

1.7

34.9

726

4310

R12

ICD-10 Finland

Heartburn

1.8

34.8

619

3496

C03DA01

ATC

spironolactone; oral

1.5

34.8

1110

7380

U01

ICPC

Dysuria/painful urination

1.7

34.7

693

4059

JHD33

NOMESCO Finland

Completing incision of fistula-in-ano

95.2

34.7

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.3

34.6

332

1466

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

11.4

34.6

J05AB11

ATC

valaciclovir; oral

1.5

34.5

1241

8483

A29

ICPC

General symptom/complaint other

1.5

34.4

1110

7398

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.9

34.4

214

741

56510

ICD-8 Finland

Anal fissure and fistula, Anal fistula

+∞

34.4

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.6

34.3

161

454

207

Kela drug reimbursment

Chronic arrhythmias

1.4

34.3

1544

11059

K58

ICD-10 Finland

Irritable bowel syndrome

3.1

34.2

193

626

D93

ICPC

Irritable bowel syndrome

4.9

34.2

115

238

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

34.2

1337

9305

M01AB55

ATC

diclofenac, combinations; oral

1.7

34.1

696

4105

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

33.8

3881

32298

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

33.8

1100

7347

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

33.7

1100

7351

A02BA04

ATC

nizatidine; systemic

1.7

33.7

787

4831

R60.9

ICD-10 Finland

Oedema, unspecified

2.0

33.6

471

2446

B81

ICPC

Anaemia vit B12/folate deficiency

2.1

33.6

398

1934

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.7

33.5

813

5039

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.7

33.5

787

4838

P03

ICPC

Feeling depressed

1.7

33.5

696

4129

A07AA09

ATC

vancomycin; oral

3.7

33.4

150

408

L15

ICPC

Knee symptom/complaint

1.4

33.4

2007

15158

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

33.4

708

4224

K57.5

ICD-10 Finland

Diverticular disease of both small and large intestine without perforation or abscess

38.3

33.3

N06AX26

ATC

vortioxetine; oral

2.0

33.3

459

2366

R30.0

ICD-10 Finland

Dysuria

2.2

33.2

339

1541

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.7

33.1

701

4181

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

3.0

33.0

196

657

M04AA01

ATC

allopurinol; systemic

1.5

32.9

1323

9256

N99.3

ICD-10 Finland

Prolapse of vaginal vault after hysterectomy

2.8

32.9

213

757

L16

ICPC

Ankle symptom/complaint

1.6

32.8

920

5922

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

32.8

2879

23070

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

32.8

1157

7870

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

32.8

604

3449

A03

ICPC

Fever

1.5

32.7

1333

9353

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

4.4

32.6

121

277

WX290

NOMESCO Finland

Other blockade of nerve

1.3

32.6

3956

33123

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.1

32.6

371

1769

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

9.6

32.6

A07EC01

ATC

sulfasalazine; oral, rectal

1.7

32.5

764

4695

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.2

32.5

349

1623

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

32.5

1213

8353

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

32.5

648

3796

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.1

32.4

384

1863

56419

ICD-8 Finland

Functional disorders of intestines, Colon irritabile aliud sive NUD

+∞

32.3

JHD30

NOMESCO Finland

Incomplete incision of fistula-in-ano

+∞

32.3

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

32.3

834

5258

JG1JM

NOMESCO Finland

Defecography MRI with 3 Tesla magnet

54.4

32.2

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.5

32.2

1276

8898

B01AC04

ATC

clopidogrel; oral

1.4

32.2

1624

11881

R03BA02

ATC

budesonide; inhalant

1.4

32.1

1641

12035

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

32.1

873

5581

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.8

32.0

533

2945

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

32.0

546

3043

U04

ICPC

Incontinence urine

1.9

31.9

475

2522

SPAT1118

SPAT

Haemorrhoid procedure

5.9

31.9

156

R51

ICD-10 Finland

Headache

2.0

31.9

435

2234

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

31.9

589

3369

H03AA01

ATC

levothyroxine sodium; systemic

1.3

31.8

2329

18146

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.8

31.8

600

3454

S04

ICPC

Lump/swelling localized

1.6

31.6

854

5444

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.1

31.5

383

1880

D02

ICPC

Abdominal pain epigastric

1.9

31.5

490

2642

N06AA12

ATC

doxepin; systemic

1.8

31.5

536

2980

A01AB04

ATC

amphotericin B; local oral

1.9

31.5

480

2571

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.8

31.5

526

2909

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

31.4

2460

19361

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

31.4

1329

9394

JGA96

NOMESCO Finland

Other proctotomy or local operation on rectum

26.9

31.4

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.9

31.4

491

2656

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

31.4

512

2810

R06AX27

ATC

desloratadine; oral

1.3

31.3

2350

18376

S06.0

ICD-10 Finland

Concussion

1.6

31.3

963

6344

5651A

ICD-9 Finland

Anal fissure and fistula, Anal fistula[FISTULA ANI]

+∞

31.2

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

5.2

31.1

189

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

4.1

31.0

125

310

SPAT1325

SPAT

Vaccination

1.3

31.0

3703

30897

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

31.0

433

2247

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

30.9

597

3461

SPAT1134

SPAT

Anoscopy

5.4

30.9

174

C09AA05

ATC

ramipril; oral

1.3

30.9

2642

21062

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.3

30.9

307

1380

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

30.9

275

1169

S22.3

ICD-10 Finland

Fracture of rib

1.7

30.8

610

3563

R39.1

ICD-10 Finland

Other difficulties with micturition

2.3

30.8

292

1282

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

30.7

903

5881

SPAT1234

SPAT

Support of social functional capacity

1.8

30.7

536

3008

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

30.6

393

1974

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

30.6

368

1799

SPAT1104

SPAT

Monitoring of emergency patient

1.7

30.5

650

3884

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

30.4

1117

7659

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.7

30.4

690

4195

SPAT1360

SPAT

Extensive global examination

1.6

30.3

753

4695

5640A

ICD-9 Finland

Functional digestive disorders, not elsewhere classified, Constipation

+∞

30.2

5641A

ICD-9 Finland

Functional digestive disorders, not elsewhere classified, Irritable colon

+∞

30.2

JF1BD

NOMESCO Finland

Very extensive small bowel CT

7.3

30.2

100

Z00.8

ICD-10 Finland

Other general examinations

1.7

30.1

656

3944

R06.5

ICD-10 Finland

Mouth breathing

1.6

30.0

742

4619

JHD96

NOMESCO Finland

Other incision of anal sphincter

58.4

30.0

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.9

29.8

426

2229

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

29.8

1571

11572

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

2.3

29.8

275

1193

WF002

NOMESCO Finland

Radical radiotherapy

1.8

29.7

513

2867

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.8

29.7

196

706

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

6.3

29.6

128

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

29.6

428

2251

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.6

29.6

904

5944

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

29.6

1718

12872

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

13.0

29.5

F45.8

ICD-10 Finland

Other somatoform disorders

1.8

29.5

520

2926

B80

ICPC

Iron deficiency anaemia

2.8

29.5

194

698

SPAT1211

SPAT

Application of soft bandage

1.6

29.4

880

5756

J01DA06

ATC

[U] cefuroxime; systemic

1.4

29.4

1364

9809

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.4

29.4

260

1103

R52.0

ICD-10 Finland

Acute pain

2.3

29.4

285

1264

SPAT1131

SPAT

Colonoscopy

2.1

29.4

326

1538

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.5

29.3

1065

7283

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.8

29.3

530

3009

H92.0

ICD-10 Finland

Otalgia

1.9

29.3

436

2316

L02

ICPC

Back symptom/complaint

1.6

29.3

776

4922

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.7

29.3

599

3535

WX704

NOMESCO Finland

Intubation

1.7

29.1

659

4003

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

29.1

713

4429

N06AB05

ATC

paroxetine; oral

1.8

29.1

524

2971

M54.1

ICD-10 Finland

Radiculopathy

2.1

29.0

350

1712

K07.60

ICD-10 Finland

Snapping jaw

2.0

29.0

383

1942

D92

ICPC

Diverticular disease

10.0

29.0

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.2

28.9

290

1308

6455

FHL

Perianal fistula surgery

40.1

28.9

JFH10

NOMESCO Finland

Total colectomy and ileostomy

16.5

28.7

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

2.4

28.7

244

1015

M01AC06

ATC

meloxicam; systemic, rectal

1.3

28.7

3600

30150

WX702

NOMESCO Finland

Supraglottic ventilation device

1.8

28.7

491

2738

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

28.7

793

5086

C10AA05

ATC

atorvastatin; oral

1.3

28.7

3985

33795

N05AA02

ATC

levomepromazine; systemic

2.0

28.6

374

1892

W19

ICD-10 Finland

Unspecified fall

1.5

28.6

911

6046

H57.1

ICD-10 Finland

Ocular pain

2.3

28.6

275

1218

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.1

28.5

341

1664

R55

ICD-10 Finland

Syncope and collapse

1.5

28.4

1079

7448

B01AB10

ATC

tinzaparin; parenteral

1.7

28.4

650

3964

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

28.4

548

3176

S97

ICPC

Chronic ulcer skin

1.8

28.3

546

3164

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

28.3

546

3164

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

28.2

2489

19893

SFA00

NOMESCO Finland

Small filling

1.5

28.2

1143

8001

K51

ICD-10 Finland

Ulcerative colitis

4.5

28.1

101

225

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.1

28.1

318

1517

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

28.1

4093

34881

L14

ICPC

Leg/thigh symptom/complaint

1.6

28.0

694

4322

N06AX12

ATC

bupropion; oral

1.9

28.0

445

2418

LCA06

NOMESCO Finland

Biopsy of endometrium

1.5

28.0

972

6581

P01

ICPC

Feeling anxious/nervous/tense

1.6

28.0

726

4581

N30

ICD-10 Finland

Cystitis

1.7

28.0

656

4026

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

28.0

824

5370

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

27.9

926

6204

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

27.9

1275

9136

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

7.4

27.9

K08.80

ICD-10 Finland

Toothache NOS

1.7

27.9

650

3982

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

1.7

27.9

575

3400

R19.4

ICD-10 Finland

Change in bowel habit

2.6

27.8

215

850

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.0

27.8

361

1820

XJW99

NOMESCO Finland

Other investigative procedure on digestive system

9.2

27.7

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

27.7

1867

14326

JG1CG

NOMESCO Finland

Extensive MRI of rectum

5.3

27.7

160

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

27.7

1200

8513

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

27.7

3643

30663

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.3

27.6

142

432

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.9

27.6

416

2219

A99

ICPC

Disease/condition unspecnature/site

1.6

27.6

750

4790

R06AE09

ATC

levocetirizine; oral

1.4

27.5

1246

8914

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.5

27.5

220

887

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.1

27.5

334

1642

UJF02

NOMESCO Finland

Peroral enteroscopy

5.8

27.4

134

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

27.3

715

4524

R06AX22

ATC

ebastine; oral

1.4

27.3

1496

11090

P06

ICPC

Sleep disturbance

1.6

27.2

815

5330

JGA35

NOMESCO Finland

Other endoscopic haemostatic procedure in rectum

53.4

27.1

5660A

ICD-9 Finland

Abscess of anal and rectal regions[ABSCESSUS ANI ET ANORECTALIS]

+∞

27.1

4552A

ICD-9 Finland

Haemorrhoids, Internal haemorrhoids with other complication

+∞

27.1

5608A

ICD-9 Finland

Intestinal obstruction without mention of hernia, Other specified intestinal obstruction[OBSTRUCTIO INTESTINALIS ,ADHESIONES INTRAABDOMINALE]

+∞

27.1

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

27.1

2360

18816

ZXA05

NOMESCO Finland

Left side

1.3

27.0

2603

21038

C08CA05

ATC

nifedipine; systemic

1.6

27.0

670

4179

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

26.9

925

6248

R03BB04

ATC

tiotropium bromide; inhalant

1.5

26.8

973

6651

XG410

NOMESCO Finland

Flow-volume spirometry

1.9

26.8

397

2108

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

26.6

1668

12644

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

26.6

279

1286

C09CA01

ATC

losartan; oral

1.3

26.6

2405

19270

SPAT1167

SPAT

Insertion of urinary catheter

2.0

26.6

338

1692

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

26.5

261

1170

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.0

26.5

355

1815

N05BE01

ATC

buspirone; oral

2.2

26.5

268

1216

J01AA04

ATC

lymecycline; systemic

1.5

26.4

1112

7836

M02AA10

ATC

ketoprofen; topical

1.4

26.4

1509

11262

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.2

26.3

275

1265

Z01.7

ICD-10 Finland

Laboratory examination

1.5

26.3

1001

6911

TQW40

NOMESCO Finland

Remowal of suture of skin

1.6

26.3

657

4101

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.4

26.2

234

1000

C10AA07

ATC

rosuvastatin; oral

1.3

26.2

2317

18498

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.3

26.2

248

1092

I84.3

ICD-10 Finland

External thrombosed hemorrhoids

3.7

26.1

116

315

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.7

26.1

594

3616

A07EA01

ATC

prednisolone; rectal

5.1

26.1

163

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.6

26.1

766

4985

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.3

26.1

236

1016

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

26.0

613

3766

D09

ICPC

Nausea

2.0

26.0

329

1644

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

5.4

25.9

148

XKW99

NOMESCO Finland

Other physiological examination of urinary or male genital system

3.1

25.8

148

486

R03AC03

ATC

terbutaline; inhalant

1.4

25.8

1259

9131

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

25.8

1146

8168

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

25.7

965

6641

K63.2

ICD-10 Finland

Fistula of intestine

260.8

25.7

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

25.6

4237

36535

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.8

25.5

474

2718

1490

FHL

Sigmoideoscopy (fiberscope)

11.2

25.5

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

3.0

25.5

150

504

L05

ICPC

Flank/axilla symptom/complaint

1.8

25.4

480

2766

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

25.2

2491

20174

ZXA10

NOMESCO Finland

Bilateral

1.3

25.2

1853

14391

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

25.2

645

4053

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

25.1

817

5448

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

10.0

25.1

N03AG01

ATC

valproic acid; systemic, rectal

1.7

25.1

516

3053

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.9

25.0

104

267

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

25.0

1299

9528

P20

ICPC

Memory disturbance

1.4

25.0

1237

8995

U71

ICPC

Cystitis/urinary infection other

1.7

25.0

544

3271

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.8

25.0

167

609

WX400

NOMESCO Finland

Inhalation anesthesy

1.9

24.9

388

2097

1370

FHL

Colonoscopy, whole colon

6.0

24.9

115

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

24.9

1298

9526

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.9

24.6

379

2038

Z50.1

ICD-10 Finland

Other physical therapy

1.7

24.6

517

3076

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

4.0

24.5

248

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.5

24.5

188

743

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

24.4

916

6303

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

24.4

3284

27624

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.9

24.3

371

1990

R63.4

ICD-10 Finland

Abnormal weight loss

2.0

24.3

301

1490

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.0

24.3

329

1689

D07AA02

ATC

hydrocortisone; topical

1.4

24.3

1200

8718

B01AF02

ATC

apixaban; oral

1.5

24.2

946

6562

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.5

24.2

900

6182

L86

ICPC

Back syndrome with radiating pain

1.7

24.2

492

2900

J02AC02

ATC

itraconazole; systemic

1.3

24.2

1636

12538

JFA52

NOMESCO Finland

Other endoscopic haemostatic procedure in colon

8.7

24.1

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.8

24.1

421

2366

AEA24

NOMESCO Finland

Removal of spinal stimulation elecrode

9.3

24.1

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.0

24.1

310

1560

L01BB02

ATC

mercaptopurine; oral

3.8

24.0

102

267

N01BB02

ATC

lidocaine; parenteral

3.8

24.0

102

267

K62

ICD-10 Finland

Other diseases of anus and rectum

15.6

24.0

D95

ICPC

Anal fissure/perianal abscess

4.8

24.0

166

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

4.9

24.0

162

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.0

24.0

296

1466

56400

ICD-8 Finland

Functional disorders of intestines, Constipation

+∞

23.9

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.6

23.9

600

3751

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

23.9

909

6273

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.5

23.9

113

324

C10AA01

ATC

simvastatin; oral

1.2

23.9

4742

41595

N06AX03

ATC

mianserin; oral

1.8

23.9

439

2509

K92.9

ICD-10 Finland

Disease of digestive system, unspecified

5.2

23.8

146

H29

ICPC

Ear symptom/complaint other

1.5

23.8

934

6486

1474

FHL

Rectoscopy and other therapeutic procedure

67.4

23.8

K63.3

ICD-10 Finland

Ulcer of intestine

67.4

23.8

F34.1

ICD-10 Finland

Dysthymia

2.1

23.7

283

1382

XJG12

NOMESCO Finland

Transrectal endoscopic ultrasonography

12.0

23.6

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.8

23.6

384

2106

R06.2

ICD-10 Finland

Wheezing

1.9

23.6

374

2033

D29

ICPC

Digestive symptom/complaint other

2.7

23.5

169

642

S16

ICPC

Bruise/contusion

2.0

23.5

295

1473

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

23.4

657

4228

N81.2

ICD-10 Finland

Incomplete uterovaginal prolapse

1.8

23.4

439

2524

A09AA02

ATC

multienzymes (lipase, protease etc.)

2.6

23.4

176

687

AN1

Coronary angiography

1.4

23.4

1189

8683

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

4.4

23.3

194

M54.8

ICD-10 Finland

Other dorsalgia

1.9

23.2

329

1716

P76

ICPC

Depressive disorder

1.7

23.2

458

2675

D82

ICPC

Teeth/gum disease

1.2

23.1

3086

25901

T90

ICPC

Diabetes non-insulin dependent

1.3

23.1

2220

17888

L04

ICPC

Chest symptom/complaint

1.7

23.0

483

2873

L29.0

ICD-10 Finland

Pruritus ani

4.0

23.0

238

6461

FHL

Anus dilatation

54.0

23.0

J01AA07

ATC

tetracycline; systemic

1.4

23.0

1268

9392

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

23.0

220

974

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.9

23.0

361

1956

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.6

22.9

657

4249

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.1

22.9

258

1231

M43.1

ICD-10 Finland

Spondylolisthesis

1.9

22.9

343

1831

D07CC01

ATC

betamethasone and antibiotics; topical

1.4

22.8

1166

8523

U13

ICPC

Bladder symptom/complaint other

2.1

22.8

276

1358

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

22.7

863

5949

L29

ICPC

Musculoskeletal sympt/complt other

1.6

22.7

672

4380

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

3.3

22.7

118

364

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

22.7

2263

18318

N41.1

ICD-10 Finland

Chronic prostatitis

2.4

22.7

196

826

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.0

22.7

279

1378

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.5

22.6

739

4931

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

3.1

22.6

123

393

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

22.5

1633

12643

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.2

22.5

240

1116

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4435

25552

2.06

315.96

3.0

2.2

—

(3022145) Colonoscopy Study observation

3387

8548

4.87

307.65

1.5

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7483

50912

1.97

307.65

5.1

3.8

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

7240

47760

2.03

307.65

5.9

4.3

g/l

35.0

35.2

2.96

6737

43871

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8464

55835

2.25

307.65

7.1

5.8

umol/l

11.1

11.8

6.67

8053

52672

(3048689) Calprotectin [Mass/mass] in Stool

2822

9461

3.46

307.65

3.0

2.1

ug/g

172.9

128.1

4.29

2265

7301

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5670

31615

2.31

307.65

3.1

2.4

u/l

59.5

59.9

0.13

5267

28874

(3031040) Bacteria [#/volume] in Urine by Automated count

9808

73677

2.03

307.65

6.1

4.2

e6/l

2217.8

1508.3

0.33

126

1116

(3037467) Urinalysis macro (dipstick) panel - Urine

10148

76629

2.09

307.65

5.8

4.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

11146

85657

2.33

307.65

9.8

6.9

u/l

79.7

79.4

0.21

10584

79993

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4908

26932

2.24

307.65

2.8

2.1

mg/l

3.2

3.0

6.17

4184

22766

(3013826) Glucose [Moles/volume] in Serum or Plasma

8989

65381

1.99

307.65

5.8

4.3

mmol/l

6.7

6.8

4.97

8587

60871

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1828

6774

2.94

307.65

1.9

1.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

8685

62470

1.98

307.65

10.3

8.6

e9/l

4.2

0.58

7659

53960

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6801

44891

1.97

307.65

3.6

2.6

ug/l

122.2

140.5

6.13

6208

41114

(40768797) Stomach Pathology biopsy report

2795

12716

2.48

307.65

1.3

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

5636

33987

2.08

307.65

3.1

2.2

—

(3032080) INR in Blood by Coagulation assay

6812

45912

1.91

304.46

11.3

9.2

inr

1.3

0.74

1971

13113

(3013707) Erythrocyte sedimentation rate by Westergren method

10494

81808

2.04

300.95

5.1

3.9

mm/h

13.3

12.8

2.45

9690

75039

(3006504) Eosinophils/100 leukocytes in Blood

7302

50522

1.90

299.29

7.2

5.7

2.8

2.9

0.30

6796

46723

(3013115) Eosinophils [#/volume] in Blood

7855

55675

1.90

298.46

7.2

5.7

e9/l

0.2

0.84

6959

48258

(3019069) Monocytes/100 leukocytes in Blood

7321

50797

1.89

296.39

7.6

6.0

8.7

1.12

6825

47209

(3022096) Basophils/100 leukocytes in Blood

7120

49020

1.89

294.71

7.3

5.8

0.7

0.38

6629

45361

(3002030) Lymphocytes/100 leukocytes in Blood

7442

52135

1.88

290.05

7.4

5.8

26.9

27.4

4.03

6902

48156

(3018010) Neutrophils/100 leukocytes in Blood

7345

51261

1.88

289.50

7.1

5.6

58.1

57.6

2.11

6841

47590

(3006315) Basophils [#/volume] in Blood

7631

53918

1.88

289.20

7.0

5.5

e9/l

0.0

0.10

6697

45955

(42870588) Differential panel, method unspecified - Blood

5696

36748

1.91

285.70

6.9

5.6

—

(3001604) Monocytes [#/volume] in Blood

7566

53666

1.86

279.57

7.0

5.5

e9/l

0.6

0.11

6628

45730

(3019198) Lymphocytes [#/volume] in Blood

7710

55294

1.85

272.03

7.0

5.5

e9/l

1.8

1.9

2.94

6871

48027

(3022948) Iron [Moles/volume] in Serum or Plasma

3135

16651

2.13

271.52

3.0

2.3

umol/l

11.8

13.0

15.58

2885

15313

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2949

15341

2.16

269.28

2.9

2.3

g/l

2.4

2.3

7.33

2708

14110

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

7811

56720

1.82

259.72

8.0

6.1

mmol/l

1.2

3.12

6589

47191

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2750

14344

2.13

247.09

3.1

2.4

20.5

22.8

14.13

2336

12128

(40768804) Tissue Pathology biopsy report

6354

43887

1.80

244.65

2.3

2.1

—

(3023368) Bacteria identified in Blood by Culture

4744

30020

1.86

243.24

5.0

4.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6611

46445

1.78

238.13

2.3

1.9

pmol/l

95.2

0.02

3498

23649

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7069

51333

1.74

220.80

7.1

5.5

mmol/l

1.2

2.19

6358

46113

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

6121

42776

1.75

218.55

4.8

3.5

ng/l

35.5

77.3

2.85

4435

29986

(3026008) Bacteria identified in Urine by Culture

5191

34621

1.78

218.14

4.0

3.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3448

20422

1.90

212.27

1.3

1.2

u/ml

1.2

1.9

3.11

849

5493

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

12815

112325

2.27

205.65

22.8

13.2

mg/l

23.0

24.5

5.49

10956

88062

(3007164) IgA [Mass/volume] in Serum or Plasma

3078

17881

1.92

199.32

1.5

g/l

2.5

0.01

1816

10720

(3002582) Erythrocytes [#/volume] in Urine

4978

33668

1.73

193.38

4.0

3.1

e6/l

106.7

112.7

0.07

4068

25456

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4974

33874

1.71

186.88

3.8

3.1

u/l

36.0

34.5

0.18

4696

31941

(3019309) Folate [Moles/volume] in Red Blood Cells

3534

21831

1.82

186.64

1.9

1.7

nmol/l

1099.9

1173.4

5.03

2596

16273

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

8812

69766

1.67

184.65

3.9

2.9

u/l

52.9

49.3

2.45

8169

64309

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6250

45333

1.67

184.27

2.6

2.1

nmol/l

78.2

77.8

0.52

5490

40221

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2161

11403

2.05

183.17

3.2

2.6

umol/l

7.6

9.5

4.19

1873

9873

(3018095) Leukocytes [#/volume] in Urine

5556

39233

1.68

180.58

4.6

3.5

e6/l

97.8

110.8

0.53

4274

27369

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3624

22843

1.78

177.41

2.1

1.7

mg/l

1.3

0.07

2732

17498

(3000570) Elastase.pancreatic [Mass/mass] in Stool

714

2268

3.26

176.97

1.4

ug/g

278.1

270.4

0.38

381

1341

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3012

17977

1.85

176.54

2.0

1.8

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1781

8908

2.14

173.44

2.8

2.3

u/l

33.4

55.5

1.59

1529

7548

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2067

10996

2.02

170.34

4.0

3.9

ug/l

17.6

28.0

1.23

1655

8969

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4916

34102

1.67

167.92

2.4

2.1

u/l

185.5

223.9

2.06

4610

31756

(3021960) Folate [Moles/volume] in Serum or Plasma

3999

26263

1.72

167.74

1.7

1.5

nmol/l

20.6

20.2

0.62

3377

22260

(3026782) Osmolality of Urine

3447

21715

1.77

167.57

3.4

2.7

mosm/kgh2o

532.8

548.3

3.93

2994

18382

(3000850) Epithelial cells [#/volume] in Urine

3614

23099

1.75

166.93

3.1

2.5

e6/l

5.0

5.6

2.62

3217

20073

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4818

33510

1.66

161.36

3.5

2.9

ng/l

1795.8

1564.7

2.18

4070

28743

(3030467) Casts [#/volume] in Urine by Automated count

4503

30841

1.67

159.77

3.9

3.0

e6/l

0.4

1.10

3571

22993

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3388

21513

1.75

158.92

4.7

3.6

ng/l

396.9

498.6

0.63

2664

17207

(3033658) Prothrombin time (PT) actual/Normal

4117

27587

1.69

158.58

5.2

3.6

87.6

88.7

1.72

4018

26875

(3027945) Reticulocytes/100 erythrocytes in Blood

2206

12321

1.93

156.88

2.5

2.4

1.8

0.83

1909

10827

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1185

5211

2.39

156.79

2.6

2.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

2555

15082

1.84

152.58

27.3

26.2

inr

1.4

0.17

474

1972

(3025941) Bacteria identified in Stool by Culture

1148

5054

2.38

151.33

1.4

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

12974

117006

2.08

149.79

25.3

15.6

mmol/l

139.5

139.7

18.03

12723

113632

(3023103) Potassium [Moles/volume] in Serum or Plasma

12981

117337

2.06

145.05

25.6

15.7

mmol/l

4.0

1.15

12714

113732

(3015377) Calcium [Moles/volume] in Serum or Plasma

5214

37895

1.59

140.94

3.6

3.3

mmol/l

2.3

2.4

6.56

4409

32782

(36304419) Bacteria [Presence] in Urine

4300

29858

1.63

140.59

3.9

2.9

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2809

17544

1.74

136.91

3.6

3.1

mmol/l

0.8

1.66

2594

16197

(3013512) EKG study

4615

32852

1.59

134.82

4.8

3.8

—

(3042936) Bacteria identified in Isolate by Culture

2450

14858

1.78

131.74

2.3

1.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

566

1900

3.06

127.31

1.5

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

11642

102861

1.68

125.29

5.6

4.6

mu/l

1.9

2.1

3.59

10559

93231

(3009261) Glucose [Presence] in Urine by Test strip

6966

54950

1.52

124.93

4.7

3.6

estimate

0.0

0.53

1377

10045

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1750

9738

1.91

123.65

2.5

2.1

g/l

0.2

1.67

1609

8995

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

11866

105525

1.70

122.69

20.3

12.8

ml/min/173m2

78.5

78.6

0.34

10329

86247

(3035350) Ketones [Presence] in Urine by Test strip

6870

54208

1.51

121.88

4.7

3.5

estimate

0.0

0.88

1377

10132

(3003327) Ova and parasites identified in Stool by Light microscopy

693

2656

2.69

121.88

1.8

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2727

17394

1.70

121.36

3.5

2.8

e6/l

2.7

2.8

0.19

1639

9324

(3021601) Nitrite [Presence] in Urine by Test strip

6875

54389

1.50

119.57

6.4

4.7

estimate

0.0

0.25

1397

10283

(3023520) Reticulocytes [#/volume] in Blood

1662

9259

1.90

116.59

2.5

e9/l

69.3

69.0

0.11

1265

6997

(3014576) Chloride [Moles/volume] in Serum or Plasma

2197

13352

1.76

115.84

7.8

6.4

mmol/l

104.5

0.38

2150

13034

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2665

17171

1.68

113.24

2.5

2.0

30.2

29.8

2.13

2565

16662

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

9910

85046

1.53

112.71

4.6

3.9

pmol/l

14.8

14.9

4.05

8857

76571

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2279

14105

1.73

112.33

6.8

5.2

mmol/l

1.0

0.78

2126

13013

(3015736) pH of Urine

5499

41941

1.50

111.79

4.2

3.3

5.6

5.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1624

9152

1.87

109.51

6.9

6.5

mmol/l

1.4

0.20

1560

8772

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2839

18741

1.64

109.24

3.3

2.7

e6/l

1.2

1.4

0.53

1742

10593

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1014

4844

2.17

108.87

1.7

1.6

g/l

1.5

1.6

0.24

857

4098

(3019225) pH of Specimen

1875

11118

1.79

106.91

4.9

3.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

690

2823

2.51

105.97

1.3

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

370

1077

3.50

105.01

1.5

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

951

4493

2.19

104.88

2.2

1.9

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

13019

120000

1.87

104.79

25.4

15.8

umol/l

81.3

78.3

12.85

13012

119948

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

13028

120152

1.87

104.04

14.1

9.8

u/l

25.3

25.8

1.79

12611

115052

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

374

1113

3.42

102.55

1.5

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

2048

12622

1.72

101.58

1.9

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

365

1090

3.41

99.53

1.5

1.4

—

(40758558) Short blood count panel - Blood

3785

27205

1.53

99.43

7.9

6.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

362

1077

3.42

99.29

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

362

1078

3.42

99.15

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

361

1074

3.42

99.02

1.5

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7771

64358

1.45

98.85

3.1

2.8

—

(3002032) Base excess in Venous blood by calculation

1697

10004

1.79

98.12

4.8

3.7

mmol/l

2.0

1.9

0.42

1392

8073

(3012544) pH of Venous blood

1753

10443

1.77

97.77

4.8

3.6

7.4

1.49

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

873

4122

2.19

96.23

2.0

1.8

—

(3037522) Nuclear Ab [Titer] in Serum

2150

13625

1.68

95.66

1.4

1.3

titre

538.7

533.3

0.04

443

2936

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1691

10060

1.77

94.54

4.8

3.6

kpa

5.8

0.01

1643

9749

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2022

12707

1.69

92.61

4.2

4.1

u/l

239.4

249.3

2.11

1873

11976

(40761511) CBC panel - Blood by Automated count

12698

117016

1.71

91.03

21.6

12.7

—

(3018418) pH of Serum or Plasma

4479

33827

1.47

90.53

4.7

3.8

7.4

0.48

881

6631

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1249

6875

1.89

89.74

4.5

3.5

kpa

5.1

0.01

1148

6342

(3009343) pH of Capillary blood

1231

6783

1.89

88.10

4.5

3.5

7.4

0.57

138

925

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1536

9093

1.77

86.91

2.3

2.2

nmol/l

355.6

381.3

5.40

1410

8324

(3000991) Gas panel - Venous blood

1509

8936

1.77

85.20

8.7

7.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1192

6570

1.89

85.12

4.4

3.5

mmol/l

1.7

1.9

0.59

892

4817

(3003396) Base excess in Arterial blood by calculation

1966

12517

1.66

85.07

7.3

6.6

mmol/l

1.1

0.10

1573

9747

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1177

6480

1.89

84.31

1.8

1.7

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1964

12528

1.66

84.30

7.3

6.6

kpa

12.2

12.3

0.24

1859

11901

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1964

12533

1.65

84.15

7.3

6.6

kpa

5.1

0.12

1864

11920

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1940

12410

1.65

82.18

1.9

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

3876

29008

1.46

79.98

2.9

2.6

umol/l

3949.0

5264.0

1.22

3291

24871

(3016502) Oxygen saturation in Arterial blood

1766

11101

1.67

79.91

7.6

7.0

95.4

95.6

0.43

1696

10667

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3370

24547

1.48

79.88

1.8

1.7

pmol/l

37694459.0

27467020.3

0.44

2706

19977

(3020779) Urea [Moles/volume] in Serum or Plasma

1568

9581

1.71

78.84

8.6

6.6

mmol/l

10.6

10.2

1.20

1470

9061

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

11454

103874

1.50

78.53

6.6

5.7

mmol/mol

40.1

40.0

0.37

10462

95130

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1381

8156

1.76

78.36

4.2

3.6

ng/l

100.4

90.5

2.65

1171

6922

(3022313) Gas panel - Capillary blood

930

4857

1.98

77.81

4.7

3.7

—

(3007461) Platelets [#/volume] in Blood

13330

125445

1.82

76.89

33.8

19.7

e9/l

249.5

248.5

0.86

13092

121428

(3024731) MCV [Entitic volume]

13333

125519

1.82

76.29

33.7

19.6

91.2

0.01

13157

123241

(3035941) MCH [Entitic mass]

13331

125503

1.82

76.15

33.7

19.6

30.2

30.3

9.26

13157

123226

(3026361) Erythrocytes [#/volume] in Blood

13333

125530

1.82

76.11

33.8

19.6

e12/l

4.4

4.5

92.08

13054

121110

(3009542) Hematocrit [Volume Fraction] of Blood

11211

101433

1.47

75.91

24.1

14.5

38.6

39.5

17.26

7430

70179

(3024354) Oxygen [Partial pressure] in Venous blood

1385

8258

1.75

75.90

4.2

3.1

kpa

4.6

4.5

0.69

1348

7967

(3000963) Hemoglobin [Mass/volume] in Blood

13333

125557

1.82

75.67

34.0

19.8

g/l

131.1

135.0

150.47

13164

123290

(3010813) Leukocytes [#/volume] in Blood

13333

125560

1.82

75.62

33.9

19.7

e9/l

6.9

6.7

3.92

13065

121128

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

851

4368

2.01

74.74

1.1

1.0

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1580

9807

1.68

74.70

3.4

2.8

ng/l

244.3

218.7

1.13

1465

8949

(3021589) Normoblasts [#/volume] in Blood

6030

49223

1.38

74.61

12.9

9.2

e9/l

0.0

0.37

5033

40108

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1560

9654

1.69

74.58

2.7

2.2

ug/l

6.5

7.5

0.81

1304

8326

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1911

12454

1.61

74.53

1.9

1.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

11920

109331

1.52

74.03

5.2

4.6

mmol/l

6.0

0.08

10710

98724

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1110

6262

1.84

73.24

1.6

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1126

6387

1.83

72.98

1.3

1.2

—

(3000494) Fungus identified in Specimen by Culture

1862

12141

1.61

72.30

1.5

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

929

4973

1.93

72.15

5.5

4.1

mmol/l

24.2

24.1

0.38

837

4433

(36660697) Celiac disease serology panel - Serum

1247

7335

1.76

71.46

1.2

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2503

17534

1.52

70.56

1.3

iu/ml

36.6

36.9

0.01

779

5540

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2369

16532

1.52

67.70

1.3

1.2

u/ml

9.1

14.0

3.34

797

6283

(40760892) CBC W Ordered Manual Differential panel - Blood

3142

23197

1.45

67.66

5.1

4.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

556

2521

2.25

67.39

1.2

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1258

7541

1.73

67.27

2.7

g/l

10.7

10.6

0.39

1143

6872

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2869

20840

1.47

67.19

3.3

3.0

mmol/l

2.5

1.28

2453

18155

(42529406) Shigella sp [Presence] in Stool by Culture

555

2527

2.24

66.58

1.3

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1027

5839

1.82

65.84

1.9

g/l

1.3

1.4

0.63

915

5270

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

549

2501

2.24

65.77

1.2

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1459

9153

1.66

65.75

2.7

2.5

g/l

65.8

66.4

2.16

1267

8253

(3049717) Cytology report of Urine Cyto stain

806

4253

1.95

65.20

2.4

2.8

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1003

5699

1.81

64.39

3.0

2.6

e6/l

0.3

0.03

984

5560

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1578

10164

1.62

63.90

8.2

7.3

g/l

118.5

121.4

7.14

1529

9778

(3041096) Erythrocytes [Presence] in Urine by Automated

3771

29071

1.40

63.01

4.5

3.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

793

4224

1.93

62.32

4.9

3.8

mmol/l

24.8

24.9

0.23

730

3873

(3017143) Hepatitis C virus Ab [Presence] in Serum

1638

10757

1.59

61.00

1.8

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1228

7524

1.69

60.33

2.5

2.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

175

454

3.89

58.93

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

173

449

3.88

58.23

1.3

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

764

4127

1.90

57.47

1.1

titre

102.8

211.7

—

127

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

120

236

5.11

57.38

2.9

3.2

mg/l

7.9

0.01

184

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5125

42116

1.33

55.31

5.1

3.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

960

5636

1.75

54.91

8.7

8.5

mmol/l

24.2

24.3

0.64

898

5209

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

507

2425

2.13

53.71

1.5

1.7

—

(3052851) Hemolysis interference index of Serum or Plasma

619

3201

1.97

52.97

3.4

3.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

781

4375

1.83

52.30

2.1

1.9

ug/l

2.4

2.2

0.13

669

3828

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

11436

105792

1.39

52.24

4.4

3.9

mmol/l

1.3

8.19

10291

95741

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2256

16346

1.45

51.94

1.6

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2198

15873

1.45

51.46

2.0

1.8

—

(3002256) Pathology report gross observation

2031

14470

1.47

50.98

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

566

2895

1.99

49.96

3.0

2.5

g/l

3.5

3.6

1.14

524

2751

(3017181) Myelocytes/100 leukocytes in Blood

1404

9309

1.56

49.57

4.2

3.9

0.9

0.22

447

2593

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

636

3425

1.89

48.20

1.7

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

946

5730

1.69

48.17

10.0

8.8

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

11762

109702

1.39

47.94

4.8

4.3

mmol/l

1.4

1.5

12.47

10659

100064

(3019060) Gas panel - Arterial blood

1146

7305

1.62

47.78

4.9

4.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

11850

110678

1.39

47.73

4.9

4.4

mmol/l

4.5

4.6

22.29

10812

101503

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

563

2922

1.96

47.64

1.7

1.6

iu/ml

0.5

8.4

0.85

123

653

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

673

3717

1.85

47.11

3.4

2.8

u/ml

0.3

0.4

1.37

388

2163

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1931

13839

1.45

46.66

4.9

4.5

32.6

32.7

0.05

1316

9187

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

656

3607

1.86

46.57

3.2

3.4

u/ml

738.5

2004.6

0.85

563

3093

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1043

6555

1.64

46.00

8.0

6.7

mmol/l

24.7

0.32

1034

6486

(3004119) Hemoglobin [Mass/volume] in Venous blood

1044

6572

1.63

45.74

4.3

3.1

g/l

125.7

128.7

3.88

1019

6412

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

720

4096

1.80

45.73

2.3

g/l

3.8

0.20

483

2920

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

722

4112

1.79

45.69

2.3

g/l

7.5

7.4

0.18

499

3050

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

721

4108

1.79

45.56

2.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

12055

113126

1.40

45.41

5.4

4.9

mmol/l

2.6

2.7

19.05

10937

103258

(3021440) Promyelocytes/100 leukocytes in Blood

1331

8894

1.55

45.19

4.3

3.9

0.1

0.89

423

2419

(3002179) Metamyelocytes/100 leukocytes in Blood

1275

8467

1.55

44.48

4.0

3.8

0.8

0.7

0.41

317

1894

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

103

226

4.58

43.35

2.4

2.6

au/ml

235.8

123.8

0.86

(3004716) Salmonella sp identified in Stool by Organism specific culture

752

4401

1.75

43.30

1.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

549

2920

1.91

43.19

1.5

iu/ml

18.8

14.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1671

11828

1.47

42.81

4.1

3.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

408

1970

2.10

42.17

5.0

5.2

iu/ml

935.2

1646.6

0.35

279

(3044889) 12 lead EKG panel

8826

79611

1.28

41.97

4.5

3.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1848

13408

1.43

41.40

1.7

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

671

3852

1.78

41.29

2.3

g/l

3.1

0.07

491

2988

(3034770) Mitochondria Ab [Titer] in Serum

493

2573

1.95

41.04

1.3

1.2

titre

948.7

941.4

0.01

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

657

3762

1.78

40.78

2.5

2.2

ug/l

414.9

609.1

1.38

613

3541

(3025159) Blasts/100 leukocytes in Blood

1239

8355

1.53

40.14

4.2

4.0

0.2

0.4

0.47

350

2046

(3009508) Creatinine [Moles/volume] in Urine

4300

35692

1.29

39.53

3.3

3.1

mmol/l

7.3

7.4

1.04

3473

29681

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

665

3862

1.75

39.30

2.2

2.3

g/l

10.4

10.3

0.13

529

3212

(3007566) Smooth muscle Ab [Titer] in Serum

488

2583

1.92

38.96

1.3

1.2

titre

117.5

160.2

0.50

236

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

804

4930

1.67

38.93

3.7

2.7

0.7

0.11

776

4699

(3017732) Neutrophils [#/volume] in Blood

1109

7358

1.55

38.65

3.2

2.9

e9/l

4.1

0.09

792

5574

(3009445) Proteinase 3 Ab [Units/volume] in Serum

759

4606

1.68

38.22

1.3

1.6

u/ml

10.5

16.5

0.68

133

(3011397) Hemoglobin [Presence] in Urine by Test strip

3200

25629

1.32

38.18

4.3

3.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

666

3905

1.74

38.05

1.2

u/ml

0.5

1.0

1.04

347

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1022

6689

1.57

37.82

9.4

8.4

0.6

0.7

1.33

1013

6641

(3037121) Protein [Mass/volume] in Urine

634

3676

1.76

37.67

3.2

3.0

g/l

0.3

0.72

276

1502

(3014007) Fractional oxyhemoglobin in Arterial blood

1015

6684

1.56

36.53

9.6

8.4

93.8

93.9

0.06

1007

6651

(3036489) Thrombin time

647

3806

1.73

36.53

2.6

2.0

22.0

21.7

0.50

581

3322

(3020682) Albumin/Creatinine [Ratio] in Urine

4273

35756

1.28

36.05

4.1

3.9

mg/mmol

12.0

9.0

2.56

2588

22362

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

748

4596

1.66

35.89

5.0

4.6

1.7

1.6

0.40

698

4300

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

502

2756

1.85

35.79

3.3

2.5

197.1

192.6

0.49

466

2613

(3007930) Methemoglobin/Hemoglobin.total in Blood

737

4519

1.66

35.65

5.0

4.7

0.9

1.85

690

4229

(3022621) pH of Urine by Test strip

1081

7260

1.53

35.54

3.9

2.9

—

(3029937) Albumin [Presence] in Urine by Test strip

3640

29910

1.29

35.37

5.1

3.9

estimate

0.0

1.17

1349

9819

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

449

2389

1.91

35.29

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

449

2389

1.91

35.29

1.4

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

411

2127

1.96

35.09

3.1

2.3

umol/l

36.2

33.1

0.61

347

1768

(3005322) IgE [Units/volume] in Serum or Plasma

908

5885

1.58

35.01

1.3

u/ml

192.8

241.9

1.22

834

5407

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1010

6717

1.54

34.72

9.5

8.3

1.4

0.31

1000

6670

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

946

6211

1.56

34.46

1.3

au/ml

51.8

50.1

0.05

270

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4370

36858

1.26

34.07

6.5

5.0

ug/l

4.0

3.5

0.41

3863

32809

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1025

6871

1.53

33.96

2.5

2.4

au/ml

24.5

25.0

0.04

351

(3012516) Albumin [Mass/volume] in Urine

4057

33934

1.27

33.87

3.3

3.2

mg/l

476.7

376.8

0.62

2543

21222

(3015235) Bicarbonate [Moles/volume] in Capillary blood

502

2805

1.82

33.81

3.5

3.0

mmol/l

24.8

0.03

440

2476

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1139

7843

1.49

33.15

2.4

1.9

—

(3002385) Erythrocyte distribution width [Ratio]

10025

92869

1.26

33.10

27.5

16.3

14.0

13.7

37.89

9865

90594

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1032

6965

1.52

33.10

7.6

6.6

mmol/l

24.7

24.6

0.17

975

6466

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

170

620

2.76

33.01

1.4

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1244

8729

1.46

32.90

2.5

2.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

137

445

3.10

32.78

1.4

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

137

445

3.10

32.78

1.4

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

585

3453

1.72

32.61

3.3

ratio

8.2

2.8

0.79

277

(3034860) Kappa light chains.free [Mass/volume] in Serum

599

3559

1.71

32.60

3.3

mg/l

149.3

62.8

0.44

483

2856

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

439

2384

1.87

32.41

1.1

u/ml

6.3

9.9

0.61

286

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

594

3531

1.71

32.27

2.5

2.4

g/l

0.8

1.0

0.59

477

2988

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

171

634

2.71

32.18

1.4

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

596

3553

1.70

32.05

3.3

mg/l

35.9

46.9

2.44

479

2855

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

552

3228

1.74

31.82

2.3

2.2

g/l

37.3

37.5

0.22

442

2742

(3047181) Lactate [Moles/volume] in Blood

569

3378

1.71

31.06

5.8

5.5

mmol/l

1.3

0.10

511

2987

(3027273) Bicarbonate [Moles/volume] in Venous blood

827

5392

1.56

31.01

3.9

3.2

mmol/l

25.3

25.2

0.19

810

5224

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

263

3.66

30.10

1.3

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1063

7360

1.48

30.01

2.3

2.1

nmol/l

10.4

12.2

8.75

898

6498

(3029634) Reagin Ab [Titer] in Serum by VDRL

265

1238

2.16

29.93

3.1

1.9

titre

7.5

8.0

0.03

(3048929) Epstein Barr virus Ab [Presence] in Serum

473

2702

1.77

29.60

1.3

—

(3045414) Leukocytes [Presence] in Urine

744

4794

1.58

29.35

2.1

1.8

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

518

3047

1.72

29.25

2.8

2.2

91.7

91.1

0.25

490

2830

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

272

1307

2.10

28.59

2.1

mg/l

26.3

27.5

0.11

361

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

350

1841

1.92

28.54

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

518

3068

1.71

28.53

1.8

1.6

g/l

1.2

1.21

491

2898

(3003181) Sodium [Moles/volume] in Urine

351

1850

1.92

28.45

1.5

1.3

mmol/l

60.3

64.6

1.14

268

1491

(3004809) Band form neutrophils/100 leukocytes in Blood

343

1794

1.93

28.44

3.7

3.4

1.4

0.04

245

1381

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

585

3583

1.66

28.40

1.6

titre

334.5

263.9

0.23

168

(3028626) Oxygen [Partial pressure] in Capillary blood

455

2602

1.77

28.38

4.0

3.2

kpa

8.1

8.2

0.47

419

2421

(3024928) Oxygen saturation in Venous blood

390

2134

1.85

28.15

4.7

3.0

—

(3019150) Specific gravity of Urine by Refractometry

2917

23881

1.28

28.09

5.0

3.9

kg/l

1.0

0.29

557

3523

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

502

2962

1.72

28.04

1.8

1.6

g/l

0.2

0.31

472

2787

(3014271) Vancomycin [Susceptibility]

156

607

2.58

26.75

3.6

2.9

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1524

11474

1.37

26.69

1.9

1.7

1.5

2.51

1295

10012

(40761536) Microorganisms panel - Urine sediment

1309

9635

1.39

26.32

5.2

3.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

487

2905

1.70

26.15

1.5

1.4

—

(40768443) Skin Pathology biopsy report

726

4776

1.55

26.12

1.2

—

(3000330) Specific gravity of Urine by Test strip

846

5760

1.50

25.90

5.0

3.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

360

1977

1.84

25.71

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

324

1723

1.90

25.60

1.3

u/ml

313.2

270.8

1.55

201

1095

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

203

3.80

25.58

1.3

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

507

3076

1.67

25.54

2.4

2.3

g/l

0.0

0.02

449

2798

(3024891) Influenza virus A+B Ag [Presence] in Specimen

447

2623

1.72

25.49

1.2

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

936

6525

1.46

25.44

3.0

3.4

pmol/l

4.4

4.5

1.98

804

5767

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

273

1373

2.01

25.40

7.5

6.0

mg/l

12.2

11.8

0.83

246

1240

(3000475) Leukocytes [#/volume] in Synovial fluid

435

2543

1.73

25.15

1.7

1.6

e6/l

11700.2

15000.6

0.83

316

1827

(4010399)

1065

7622

1.43

25.13

1.5

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

602

3832

1.59

25.01

1.1

u/ml

1.1

12.0

0.96

(3026389) Candida sp identified in Specimen by Organism specific culture

289

1499

1.94

24.62

1.5

1.3

—

(3021788) Differential panel - Synovial fluid

352

1959

1.81

24.10

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

472

2862

1.67

23.85

2.5

2.3

g/l

0.0

1.01

415

2598

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

324

3.07

23.52

1.4

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

462

2820

1.66

22.77

2.5

2.3

g/l

0.0

0.00

412

2591

(3021901) Oxygen saturation in Capillary blood

361

2074

1.76

22.23

3.1

2.8

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

222

1092

2.05

22.03

3.6

3.3

60.9

58.4

0.77

131

690

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

421

2534

1.68

21.90

1.6

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

208

1002

2.09

21.83

3.2

2.7

—

(3000492) Spirometry study

1267

9554

1.36

21.78

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

111

410

2.72

21.21

7.3

4.4

mg/l

58.7

1183.5

0.84

289

(3032057) Clostridioides difficile [Presence] in Stool

198

3.54

21.05

1.7

1.9

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

411

2485

1.67

21.03

1.2

1.1

—

(3045424) Erythrocytes [Presence] in Urine

317

1784

1.79

20.97

1.6

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

240

1237

1.95

20.90

1.4

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

372

2196

1.71

20.82

2.8

3.3

u/ml

817.6

928.5

0.09

320

2018

(40760888) Immunoglobulin light chains.free panel - Serum

437

2694

1.64

20.74

3.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

299

1663

1.81

20.58

1.3

1.2

—

(4035726)

1309

10005

1.34

20.53

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

276

1499

1.86

20.51

1.5

1.6

g/l

0.7

0.8

1.14

217

1128

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

430

2649

1.64

20.47

1.4

1.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

123

488

2.53

20.38

3.1

2.2

93.5

97.4

0.62

109

460

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

212

1057

2.02

20.31

2.5

1.7

titre

3588.6

1619.5

1.07

(3037756) Immunofixation for Serum or Plasma

389

2343

1.68

20.21

1.7

1.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

419

2573

1.65

20.20

2.3

2.2

g/l

125.5

128.3

1.51

307

1876

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

107

398

2.70

20.19

2.2

1.8

151.5

150.4

0.04

370

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

259

1390

1.88

19.99

2.4

2.7

u/ml

166.6

466.0

0.68

251

1338

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

421

2608

1.63

19.61

2.5

2.2

u/l

3143.3

5563.4

1.65

146

1003

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

335

1958

1.73

19.47

1.5

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

639

4355

1.49

19.46

1.9

u/l

39.2

38.6

0.31

568

3789

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

332

1937

1.73

19.42

1.5

1.4

u/ml

18.0

18.3

—

(3010421) pH of Blood

467

2980

1.58

19.25

4.2

3.7

7.4

0.00

392

2546

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

6.28

19.21

3.4

2.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

479

3088

1.57

18.90

2.0

1.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

502

3271

1.55

18.89

1.7

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

228

1198

1.92

18.81

4.2

3.9

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

295

2.89

18.31

2.1

1.9

190.6

181.0

0.27

279

(3044927) Protein electrophoresis panel - Urine

206

1058

1.96

18.19

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

152

698

2.19

18.13

1.8

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

236

1272

1.87

18.03

1.6

1.3

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

323

2.76

17.67

2.1

1.7

umol/l

2.2

1.9

1.32

308

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

435

2792

1.57

17.52

1.3

1.2

u/ml

44.8

39.2

0.17

168

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

301

1763

1.72

17.41

1.5

1.4

u/ml

107.5

118.8

1.01

400

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

163

782

2.09

17.40

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

564

3835

1.49

17.39

2.5

2.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

273

1559

1.76

17.27

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

474

3116

1.54

17.17

6.3

3.9

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

296

1733

1.72

17.15

1.4

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

290

2.84

17.10

1.9

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

953

7136

1.36

17.06

1.6

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

245

1363

1.81

16.93

1.6

1.5

60.2

60.0

0.02

161

837

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

211

1122

1.89

16.84

3.3

nmol/l

15.5

10.8

0.24

201

1104

(3051651) Icteric interference index of Serum or Plasma

134

605

2.22

16.70

3.6

3.9

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

400

2549

1.58

16.64

1.3

u/ml

9.1

4.7

0.31

270

(3008037) Lactate [Moles/volume] in Venous blood

400

2550

1.58

16.61

3.9

3.0

mmol/l

1.6

1.7

1.51

391

2491

(3039000) Anion gap in Blood

387

2453

1.59

16.47

6.7

6.2

mmol/l

11.2

0.08

347

2197

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

542

3698

1.48

16.45

2.5

1.8

—

(3018572) Chloride [Moles/volume] in Blood

387

2454

1.59

16.44

6.7

6.2

mmol/l

104.9

105.2

0.41

347

2198

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1262

9893

1.30

16.41

4.2

3.6

mmol/l

1.2

1.79

1120

8493

(40761535) Cells panel - Urine sediment

1187

9242

1.31

16.23

4.0

3.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

402

2580

1.57

16.23

1.3

u/ml

7.2

6.8

0.06

422

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3375

29460

1.19

16.11

5.0

4.4

20.9

22.3

5.53

1689

14885

(3027456) Digoxin [Moles/volume] in Serum or Plasma

397

2550

1.57

15.97

3.5

3.1

nmol/l

0.8

0.06

284

1992

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

663

4733

1.42

15.83

2.6

1.9

—

(3003694) ABO and Rh group [Type] in Blood

3419

29919

1.19

15.80

1.5

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

386

2471

1.58

15.77

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

264

1534

1.73

15.76

2.8

2.6

u/ml

394.8

2380.9

1.66

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

888

6667

1.35

15.62

1.2

iu/ml

108.9

146.1

2.47

325

2511

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

177

3.28

15.61

2.1

1.7

au/ml

72.5

102.7

—

(3018405) Lactate [Moles/volume] in Arterial blood

553

3836

1.46

15.44

4.6

3.9

mmol/l

1.4

0.23

535

3770

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

208

1134

1.84

15.40

1.3

1.2

u/l

53.3

65.2

2.27

138

767

(3038515) Glucose [Moles/volume] in Venous blood

378

2425

1.57

15.31

4.1

3.1

mmol/l

7.3

7.7

2.82

371

2376

(3012501) Base excess in Blood by calculation

401

2610

1.55

15.24

4.4

3.7

mmol/l

2.7

2.6

0.25

276

1748

(3027315) Oxygen [Partial pressure] in Blood

403

2626

1.55

15.24

4.4

3.7

kpa

8.5

0.00

392

2558

(3013290) Carbon dioxide [Partial pressure] in Blood

401

2611

1.55

15.21

4.4

3.7

kpa

5.0

0.03

390

2544

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

227

1276

1.79

15.21

1.1

g/l

1.5

0.21

213

1148

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

158

793

2.00

14.99

1.4

1.3

titre

—

(3003338) MCHC [Mass/volume]

9927

94380

1.16

14.98

29.4

17.3

g/l

331.0

332.1

26.44

9840

93509

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

278

2.74

14.94

1.3

1.1

95.4

103.2

0.82

256

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

238

2.86

14.52

2.4

1.7

mg/l

8.8

9.4

0.40

192

(3019832) Treponema pallidum Ab [Presence] in Serum

960

7372

1.32

14.48

1.8

1.6

—

(3044941) Cell count panel - Synovial fluid

273

1641

1.67

14.43

1.5

1.4

—

(1616796) Gas panel - Central venous blood

388

2540

1.54

14.39

3.7

3.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

139

678

2.06

14.29

1.7

1.5

umol/l

66.7

71.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

418

2785

1.51

14.29

2.0

1.9

mg/l

10.5

11.4

1.57

380

2583

(3051593) INR in Capillary blood by Coagulation assay

119

552

2.16

13.96

8.2

11.8

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

207

1164

1.79

13.90

1.1

u/ml

3.6

4.2

0.24

554

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

333

2124

1.58

13.87

1.3

1.2

u/ml

8.5

4.4

0.53

155

(3051611) Lipemic interference index of Serum or Plasma

204

1143

1.79

13.87

3.6

3.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

172

915

1.89

13.80

1.8

2.1

umol/l

9.4

8.8

0.10

133

665

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

231

1345

1.73

13.75

1.3

nmol/l

0.2

0.3

0.46

105

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

265

2.65

12.93

1.2

77.0

88.1

1.06

130

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2438

21034

1.19

12.93

3.5

3.1

ug/l

0.8

2.40

1683

14256

(3011288) Drugs identified in Urine by Screen method

307

1956

1.58

12.88

3.1

3.3

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

128

3.44

12.82

1.7

2.0

pmol/l

39.2

59.6

0.81

106

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

105

482

2.18

12.69

2.9

2.7

—

26.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

295

1869

1.59

12.68

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

212

1234

1.73

12.67

1.6

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

220

1294

1.71

12.67

2.6

3.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

112

528

2.13

12.66

1.7

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

112

528

2.13

12.66

1.7

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

112

528

2.13

12.66

1.7

1.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

276

1724

1.61

12.59

1.9

1.7

—

(3036670) Protein [Mass/volume] in Synovial fluid

322

2.46

12.55

1.2

g/l

41.1

40.1

0.24

169

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

112

530

2.12

12.54

1.7

1.8

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

225

1338

1.69

12.45

1.3

nmol/l

4.3

2.7

0.17

218

1293

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

415

2847

1.47

12.34

4.1

3.5

mg/l

1.7

1.6

1.69

383

2584

(40767503) Oxygen content in Capillary blood by calculation

365

2440

1.51

12.34

2.7

2.5

15.8

16.2

0.92

193

1250

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

209

1225

1.71

12.21

1.5

—

(3023420) DNA double strand Ab [Units/volume] in Serum

184

1043

1.77

12.09

1.6

1.4

iu/ml

28.0

26.3

—

(3014051) Protein [Presence] in Urine by Test strip

365

2451

1.50

12.08

2.5

2.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

361

2419

1.50

12.08

1.4

u/l

10.3

10.5

0.10

294

1951

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

201

2.84

12.08

1.4

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

275

2.55

12.03

1.2

1.1

81.4

87.7

0.67

131

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

151

807

1.88

12.02

1.2

titre

191.4

179.6

0.07

140

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

414

2856

1.46

11.98

1.4

1.3

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

342

2.37

11.94

2.2

1.6

umol/l

29.2

29.6

0.10

327

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

325

2137

1.53

11.89

1.2

u/ml

0.8

17.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

237

1447

1.65

11.88

3.0

2.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

246

1517

1.63

11.86

1.3

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

105

496

2.12

11.84

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

715

5420

1.33

11.82

3.7

3.4

u/ml

46.9

69.7

1.46

694

5230

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

150

807

1.87

11.71

1.2

titre

290.0

177.5

—

(3038026) Centromere Ab [Units/volume] in Serum

152

824

1.85

11.59

1.2

u/ml

57.2

46.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

206

1222

1.69

11.54

1.3

—

(3020891) Body temperature

594

4399

1.36

11.46

5.5

4.5

—

(4268621)

166

929

1.79

11.42

2.4

2.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

103

490

2.11

11.42

2.4

—

(3023419) Bacteria identified in Sputum by Culture

224

1363

1.65

11.40

2.7

2.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

129

667

1.94

11.37

1.3

1.4

umol/l

13.4

12.7

0.45

122

629

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

102

485

2.11

11.33

1.3

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

102

485

2.11

11.33

1.3

1.6

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

187

2.84

11.24

1.2

101.9

108.4

0.74

177

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

182

2.86

11.20

1.2

75.9

77.5

0.07

(3022806) Fractional oxyhemoglobin in Capillary blood

234

1447

1.63

11.18

1.8

89.5

0.05

229

1428

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

182

1053

1.74

11.18

3.9

3.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

250

1574

1.60

11.10

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

173

989

1.76

11.09

1.6

1.4

e6/l

228362.9

129070.6

0.78

119

676

(3016038) Potassium [Moles/volume] in Urine

128

667

1.93

11.04

1.3

1.2

mmol/l

31.1

35.7

1.40

568

(3026250) Tacrolimus [Mass/volume] in Blood

362

2.27

10.95

34.0

34.1

ug/l

6.9

7.3

1.27

330

(3014148) Varicella zoster virus Ab [Titer] in Serum

192

1136

1.70

10.89

1.2

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

185

2.81

10.88

2.6

2.8

—

(3043409) Potassium [Moles/volume] in Arterial blood

462

3315

1.41

10.82

5.0

4.2

mmol/l

3.9

0.70

427

3103

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

203

1224

1.67

10.73

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

221

2.63

10.65

1.4

1.3

g/l

24.7

57.1

0.66

176

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

129

683

1.89

10.62

1.8

1.5

u/l

6.0

5.6

0.11

315

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

217

1335

1.63

10.61

1.1

—

(3019977) pH of Arterial blood

117

601

1.95

10.55

2.2

2.3

7.4

1.19

229

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

183

2.79

10.51

1.2

67.4

71.7

0.25

(3052592) Norovirus Ag [Presence] in Stool

206

2.67

10.46

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

129

688

1.88

10.40

1.1

mg/l

299.5

292.4

0.45

119

620

(3005570) Glucose [Moles/volume] in Urine

195

1180

1.66

10.19

2.1

1.8

—

1.5

—

(3008898) HLA-B27 [Presence]

427

3055

1.41

10.19

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

304

2042

1.50

10.13

1.3

1.2

u/ml

27.4

48.3

2.56

204

(3010375) cycloSPORINE [Mass/volume] in Blood

394

2.16

10.12

30.0

27.6

ug/l

110.2

114.8

0.31

338

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

421

2.12

10.07

3.4

1.9

umol/l

120.2

130.6

0.13

220

(3021387) Prolactin [Units/volume] in Serum or Plasma

398

2819

1.42

10.06

1.9

1.7

mu/l

316.7

302.6

0.34

365

2555

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

144

804

1.80

10.05

1.2

u/ml

69.9

81.5

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

139

769

1.81

10.00

1.2

u/ml

2.5

8.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3256

29238

1.15

9.99

1.7

1.6

mmol/l

1.4

1.3

0.96

2700

24226

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

358

2.21

9.96

1.1

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

228

1443

1.59

9.96

1.3

1.2

u/ml

3.2

3.9

0.29

466

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

144

807

1.79

9.93

1.2

u/ml

34.8

39.0

0.09

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

203

1252

1.63

9.86

1.4

1.3

u/l

27.5

28.8

0.20

162

1045

(3011648) Oxygen content in Venous blood

137

762

1.80

9.70

4.5

2.3

10.4

10.9

0.79

137

762

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

364

2.17

9.58

2.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

174

1040

1.68

9.57

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1691

14484

1.19

9.55

8.3

6.8

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

404

2.11

9.53

1.1

u/ml

11.3

8.9

0.16

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

124

674

1.85

9.47

2.4

2.6

e6/l

614.6

681.3

0.43

265

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

108

565

1.92

9.29

1.1

u/l

23.9

26.3

0.21

411

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

220

1406

1.57

9.25

1.3

1.2

u/ml

4.0

4.3

0.20

102

599

(3047007) Chlamydophila sp Ab [Presence] in Serum

206

1297

1.60

9.23

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

277

1865

1.49

9.17

1.4

—

(4062490)

161

954

1.69

9.16

1.2

1.4

—

(21494434) Karyotype in Bone marrow

153

897

1.71

9.06

1.2

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

121

3.06

9.04

3.5

1.7

—

(21494815) CD4 cells/100 lymphocytes in Specimen

147

853

1.73

9.04

2.1

2.2

37.6

42.5

0.56

110

(4015189)

278

2.31

8.96

1.7

2.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

107

567

1.89

8.87

1.1

u/l

83.2

88.8

0.33

434

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

213

1366

1.57

8.84

1.1

118.2

116.9

0.22

193

1209

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

166

1003

1.66

8.80

1.1

91.7

95.3

0.93

158

931

(3033799) Differential panel - Peritoneal fluid

312

2.22

8.80

2.1

1.8

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

492

1.96

8.79

1.2

1.1

iu/ml

2.4

5.2

—

(3008295) Osmolality of Serum or Plasma

167

1012

1.66

8.76

1.5

1.4

mosm/kgh2o

275.8

279.7

1.19

115

784

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

107

571

1.88

8.69

1.2

—

(40768441) Liver Pathology biopsy report

130

737

1.77

8.68

1.4

1.3

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

222

1444

1.54

8.67

1.1

au/ml

13.5

10.8

—

(3041672) Baker's yeast Ab [Presence] in Serum

5.31

8.66

1.1

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

261

1760

1.49

8.61

1.8

1.6

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

159

956

1.67

8.60

1.2

1.4

g/l

2.8

3.0

0.92

121

664

(3027135) IgG subclass 1 [Mass/volume] in Serum

159

956

1.67

8.60

1.2

1.4

g/l

6.8

6.9

0.19

124

663

(3024139) IgG subclass 3 [Mass/volume] in Serum

159

956

1.67

8.60

1.2

1.4

g/l

0.5

0.4

0.15

126

663

(3000093) Morphology [Interpretation] in Blood Narrative

169

1033

1.64

8.58

1.2

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

113

617

1.84

8.55

1.1

—

(4024509)

177

1098

1.62

8.47

1.7

1.5

—

(3011985) Renin [Units/volume] in Plasma

207

1337

1.55

8.36

1.4

mu/l

63.3

63.7

0.01

179

1181

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

113

622

1.82

8.35

1.4

1.2

u/l

30.8

21.9

0.92

521

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

226

1490

1.52

8.32

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

140

823

1.71

8.26

1.6

1.3

promille

1.4

1.3

0.30

110

627

(4306422)

215

1406

1.54

8.22

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

148

886

1.68

8.16

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

148

886

1.68

8.16

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

148

886

1.68

8.16

1.6

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

115

642

1.80

8.12

1.4

1.2

u/l

104.0

84.1

1.19

100

551

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

293

2048

1.44

8.06

3.5

3.1

—

(4094501)

373

2722

1.38

8.01

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

446

1.95

8.00

1.1

1.2

u/l

186.7

393.7

2.29

404

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

155

945

1.65

7.98

1.6

1.7

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

372

2.05

7.96

2.3

1.8

e6/l

3344.0

4292.4

0.12

255

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

195

2.46

7.84

1.4

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

515

1.87

7.73

3.6

3.2

mu/l

27.3

26.5

0.08

482

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

146

885

1.65

7.71

1.4

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

282

1976

1.43

7.68

1.3

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

222

1487

1.50

7.62

5.1

4.5

umol/l

344.1

361.5

0.97

187

1247

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.79

7.49

1.3

1.2

—

(4146454)

187

1216

1.54

7.39

2.5

2.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

322

2328

1.39

7.36

2.4

2.3

—

(3016879) Cocaine [Presence] in Urine

378

2809

1.35

7.28

2.3

2.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

240

2.25

7.25

1.7

1.5

ug/l

0.4

0.00

146

(3048879) Bone marrow aspiration report

325

2.06

7.23

1.6

1.8

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

165

1049

1.58

7.21

1.8

1.5

27.6

28.8

0.17

632

(3013466) aPTT in Blood by Coagulation assay

4.29

7.19

1.1

37.3

37.7

0.04

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

333

2.04

7.16

2.4

1.8

u/ml

30468.8

67421.7

0.35

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

213

1436

1.49

7.12

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

287

2048

1.41

7.09

1.3

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

191

1260

1.52

7.08

1.3

1.4

pmol/l

352.1

280.8

0.82

139

969

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

219

1489

1.48

7.02

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

102

576

1.77

7.00

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

260

1828

1.43

6.99

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

540

1.80

6.98

1.8

1.4

nmol/l

1.4

1.2

0.52

418

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

108

622

1.74

6.93

2.6

2.7

e9/l

0.2

1.18

536

(3036071) Salmonella sp Ab [Titer] in Serum

284

2.12

6.92

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

102

579

1.77

6.89

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1778

15681

1.15

6.86

1.5

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

108

2.87

6.86

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

111

647

1.72

6.83

2.5

2.6

e6/l

480.1

506.3

0.24

538

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

279

2.12

6.82

2.8

3.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

247

1729

1.43

6.82

1.3

u/l

34.0

36.8

0.14

214

1475

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

339

2505

1.36

6.80

1.5

—

(40768800) Prostate Pathology biopsy report

325

2388

1.37

6.76

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1053

8917

1.19

6.76

3.0

2.7

ml/min/173m2

64.4

63.6

0.29

490

3556

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

561

1.77

6.73

3.5

3.8

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

104

2.89

6.70

1.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

340

2526

1.35

6.60

1.3

1.4

mg/l

572.1

544.7

0.18

319

2397

(3028300) Cannabinoids [Presence] in Urine

401

3056

1.32

6.56

2.3

2.1

—

(3045142) Bone marrow Pathology biopsy report

182

1212

1.51

6.50

1.4

1.3

—

(3027008) Opiates [Presence] in Urine

399

3048

1.32

6.42

2.2

2.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

496

1.80

6.42

1.7

1.6

ug/l

11.7

9.1

0.38

451

(44790048)

173

1143

1.52

6.42

1.5

1.4

—

(44790047)

173

1143

1.52

6.42

1.5

1.4

—

(44790049)

173

1143

1.52

6.42

1.5

1.4

—

(44806118)

173

1143

1.52

6.42

1.5

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

497

3920

1.28

6.28

1.4

iu/l

26.4

30.7

2.28

429

3359

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

151

974

1.55

6.26

2.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

465

1.81

6.21

1.4

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

119

727

1.64

6.19

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

119

727

1.64

6.19

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

119

727

1.64

6.19

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

344

2588

1.34

6.18

1.8

iu/l

4.0

8.0

0.63

111

925

(37021550) Renin [Units/volume] in Plasma --upright

187

2.30

6.13

1.3

mu/l

82.8

70.8

0.20

142

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

417

1.85

6.11

1.5

1.7

nmol/l

3.4

3.5

0.04

346

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

326

1.97

6.10

2.5

2.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

326

1.97

6.10

2.5

2.1

—

(3006270) Folate [Moles/volume] in Blood

146

942

1.55

6.06

1.2

nmol/l

340.9

354.1

0.36

118

767

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

320

1.97

6.06

2.2

1.6

e6/l

8934.3

11719.8

0.16

170

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

132

833

1.59

6.03

1.4

1.6

u/ml

24.6

24.0

0.05

182

(3000764) Benzodiazepines [Presence] in Urine

394

3033

1.31

6.03

2.3

2.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

314

1.98

6.02

1.5

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

136

868

1.57

5.93

1.3

mmol/l

11.9

11.6

0.09

221

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

117

721

1.63

5.90

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

117

721

1.63

5.90

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

986

8405

1.18

5.90

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

249

2.09

5.88

1.2

1.1

—

(3011412) CD3 cells [#/volume] in Blood

147

957

1.54

5.88

2.4

e9/l

1.1

0.33

601

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

117

722

1.62

5.87

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

227

1615

1.41

5.80

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

192

1327

1.45

5.75

6.3

6.9

mmol/l

7.2

7.6

0.97

163

1096

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

180

2.28

5.74

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

119

743

1.60

5.71

2.1

2.0

nmol/l

17.3

17.4

0.03

106

704

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

143

932

1.54

5.70

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

114

709

1.61

5.57

1.2

1.3

titre

28.6

66.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

579

1.68

5.56

1.1

nmol/l

3.6

5.9

0.48

116

(3020876) Protein [Mass/time] in 24 hour Urine

145

958

1.52

5.45

2.1

1.9

g/24h

0.3

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

173

1185

1.46

5.45

1.0

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

153

2.35

5.44

1.5

1.6

ug/l

88.9

115.3

0.91

131

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

145

960

1.51

5.40

1.6

1.5

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

516

1.71

5.40

7.6

5.1

u/ml

5621.0

7838.9

0.09

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

258

2.02

5.38

1.2

1.3

nmol/l

199.1

130.3

0.99

186

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

296

2227

1.33

5.37

1.2

1.3

mmol/l

3.7

3.8

1.15

276

2094

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

333

2554

1.31

5.29

1.8

1.7

nmol/l

40.8

42.4

0.67

318

2476

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.40

5.28

1.3

1.7

—

(3042631) Mycobacterium sp identified in Specimen

219

1576

1.39

5.28

2.5

2.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

421

3338

1.27

5.17

2.1

1.8

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

120

2.50

5.17

1.2

1.4

nmol/l

4.7

366999.8

1.08

103

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

427

1.76

5.13

2.0

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

248

1831

1.36

5.12

1.9

1.8

pmol/l

183.8

199.5

1.67

230

1713

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

139

2.37

5.11

2.2

3.6

umol/l

41.3

42.5

0.13

112

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

124

805

1.54

5.08

1.3

mmol/l

2.1

0.03

114

750

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.84

5.06

1.7

1.8

umol/l

57.2

44.6

1.09

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

146

2.33

5.05

2.1

2.8

mg/l

36.7

57.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

422

1.76

5.04

1.9

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

422

1.76

5.04

1.9

2.0

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

400

1.78

5.04

1.7

1.6

iu/ml

2226005.1

800918.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

542

1.66

5.03

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

115

736

1.57

5.02

1.2

1.3

titre

61.3

425.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

521

1.67

4.97

1.2

—

(3010503) CD19 cells [#/volume] in Blood

613

1.62

4.97

2.4

e9/l

1.1

0.4

0.40

589

(3001186) Copper [Moles/volume] in Serum or Plasma

199

2.11

4.94

1.3

umol/l

16.9

17.0

0.05

177

(3026692) Albumin [Mass/volume] in Peritoneal fluid

253

1.98

4.93

1.6

1.3

g/l

13.4

13.2

0.05

201

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

569

1.64

4.90

1.1

iu/ml

6.5

10.5

0.78

131

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

302

2312

1.31

4.89

1.4

pmol/l

183.6

163.2

0.17

289

2253

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.33

4.86

1.4

1.8

—

(21494755) Public health laboratory ask at order entry panel

756

8857

0.84

4.82

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

326

1.84

4.81

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

156

1076

1.45

4.80

1.3

—

(3042733) HLA Ab [Presence] in Serum

284

1.90

4.78

5.2

4.5

—

(3027944) Amphetamines [Presence] in Urine

379

3000

1.27

4.76

2.1

—

(40762365) Oxygen content in Arterial blood by calculation

163

2.21

4.75

2.5

2.8

ml/dl

14.4

14.8

0.29

147

(3039162) Centromere protein B Ab [Units/volume] in Serum

179

1272

1.41

4.69

1.3

1.2

u/ml

93.5

55.9

1.27

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

145

2.28

4.67

2.1

2.0

umol/l

13.0

17.4

1.92

145

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

427

1.71

4.58

3.4

2.4

—

(1002224) Polysomnography panel

464

3778

1.23

4.56

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

550

1.62

4.54

1.5

3.3

3.6

0.08

121

(3004451) EKG impression Narrative

550

1.62

4.54

1.4

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

158

1106

1.43

4.52

1.7

1.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

201

1467

1.37

4.52

1.5

e6/l

1845.2

2602.9

0.51

157

1061

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

214

2.01

4.48

1.3

1.2

pmol/l

293.9

304.7

0.09

155

(3028308) Erythrocytes [#/volume] in Pleural fluid

185

1334

1.39

4.48

1.5

e6/l

59714.7

51375.0

0.13

117

790

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

129

2.33

4.47

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

136

2.28

4.42

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

433

1.69

4.38

1.2

1.1

iu/ml

166.6

164.9

0.02

425

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

3.71

4.35

1.5

u/l

0.3

0.1

—

(3016018) Differential panel - Cerebral spinal fluid

153

1075

1.43

4.31

1.3

1.5

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

3.33

4.31

1.1

1.0

u/l

74.2

46.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

317

1.80

4.28

1.3

1.2

g/l

0.3

0.65

257

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

482

1.64

4.27

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

132

2.27

4.26

1.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

560

1.59

4.25

2.4

2.7

36.1

39.1

0.63

200

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

122

825

1.48

4.20

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.90

4.15

1.1

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

285

2220

1.29

4.13

1.3

1.4

e6/l

15.7

25.5

0.77

220

1720

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

134

2.24

4.12

4.3

5.5

ug/min

61.3

45.6

0.49

106

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

285

2221

1.29

4.11

1.4

1.5

e6/l

3832.7

1377.8

0.35

230

1819

(44813793)

103

676

1.53

4.10

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

327

2594

1.27

4.09

1.3

miu/ml

231.3

218.8

0.21

127

1165

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

480

1.63

4.09

12.1

11.3

mmol/l

0.6

0.38

433

(3012565) Volume of 24 hour Urine

550

1.58

4.09

2.4

2.1

1899.1

1926.0

0.08

477

(3044007) Cell count panel - Peritoneal fluid

293

1.81

4.08

2.1

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

427

1.66

4.07

1.1

miu/ml

1552.4

1496.2

0.16

427

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

149

2.15

3.99

1.4

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

111

2.34

3.97

1.1

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

311

1.77

3.94

1.1

—

(3013727) Leukocytes other/100 leukocytes in Blood

363

1.71

3.94

3.8

52.4

53.7

0.16

345

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

319

1.76

3.91

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

636

1.53

3.90

1.8

1.9

u/field

2.6

2.9

0.13

440

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

164

2.07

3.89

1.4

1.3

ng/l

2964.0

166.4

0.48

116

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

171

2.05

3.87

1.0

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

221

1681

1.32

3.85

1.1

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

144

1024

1.41

3.84

1.7

1.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

105

703

1.50

3.84

1.4

1.3

u/ml

0.4

1.2

1.52

340

(3025315) Body weight

2.68

3.80

7.9

3.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

140

993

1.41

3.79

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

101

2.38

3.79

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

127

886

1.44

3.77

2.1

1.8

mg/l

4.0

4.1

0.08

118

841

(3017569) Oxygen content in Arterial blood

530

1.57

3.77

2.1

2.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.91

3.72

1.1

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.91

3.72

1.2

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

540

1.56

3.71

2.1

1.9

—

(4211845)

566

1.54

3.65

4.5

3.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

105

712

1.48

3.63

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

591

1.52

3.63

1.2

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

139

995

1.40

3.60

2.1

u/field

3.0

2.1

0.56

378

(3009871) Measles virus Ab [Titer] in Serum

298

1.75

3.59

1.8

1.7

—

(3003434) Protein [Mass/volume] in Pleural fluid

217

1665

1.31

3.58

1.5

1.4

g/l

30.6

32.5

1.39

194

1482

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

561

1.53

3.58

1.1

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.74

3.57

1.7

1.5

mg/l

4.1

2.0

0.50

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

212

1.89

3.55

1.2

1.1

—

(3000285) Sodium [Moles/volume] in Blood

150

2.07

3.54

1.1

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.44

3.53

6.1

5.0

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

2.50

3.53

1.8

1.9

74.4

66.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

256

1.80

3.51

1.1

—

(3028433) Virus identified in Specimen by Culture

346

1.68

3.48

1.3

1.1

—

(3006462) Nitrate [Presence] in Urine

509

1.55

3.48

4.7

3.2

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

186

1.94

3.45

1.1

1.4

titre

36.8

324.9

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

187

1416

1.32

3.41

1.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.76

3.40

1.2

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

231

1.82

3.35

1.2

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

253

1.78

3.34

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

154

2.01

3.33

1.4

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

154

2.01

3.33

1.4

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

154

2.01

3.33

1.4

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

193

1476

1.31

3.29

1.7

1.9

ug/l

22.8

23.2

0.03

183

1439

(40761539) Cells [Type] in Urine sediment by Light microscopy

284

1.73

3.29

1.1

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

190

1.90

3.26

1.1

1.2

umol/24h

0.7

0.38

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

263

1.75

3.24

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

227

1.81

3.21

1.6

1.5

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

2.67

3.21

1.1

u/field

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.86

3.18

10.6

8.7

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

379

1.61

3.17

1.4

—

(3034426) Prothrombin time (PT)

310

1.68

3.16

1.3

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

118

842

1.40

3.16

1.6

1.4

u/l

13.2

12.9

0.11

109

809

(3028679) Herpes simplex virus Ab [Presence] in Serum

474

1.54

3.15

1.2

1.1

—

(3042517) Benzodiazepines panel - Urine

2.35

3.13

1.8

2.6

—

(40757373) Influenza virus identified in Isolate

229

1.79

3.13

1.5

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

222

1.80

3.12

1.2

mg/l

0.5

50.5

1.01

165

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

150

1117

1.35

3.10

1.4

1.3

u/l

592.1

478.0

0.21

142

1062

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.08

2.0

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

558

1.49

3.06

1.4

1.5

u/l

6.1

6.4

0.18

471

(40768446) Kidney Pathology biopsy report

375

1.60

3.05

1.7

1.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

407

1.57

3.03

1.2

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

140

2.00

2.98

1.9

1.8

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

120

2.08

2.96

1.9

2.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

226

1.77

2.96

2.3

2.6

mmol/l

7.2

7.9

0.64

129

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

111

794

1.40

2.96

1.9

1.6

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

271

1.70

2.95

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

219

1.78

2.95

2.5

2.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

122

889

1.37

2.92

1.3

u/l

11.6

13.0

0.54

109

823

(21494890) Protein electrophoresis panel - 24 hour Urine

152

1148

1.33

2.89

2.4

2.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

273

1.69

2.88

1.2

—

(3023410) Appearance of Cerebral spinal fluid

131

968

1.36

2.88

1.5

1.6

—

(3012441) Differential panel - Pleural fluid

168

1288

1.31

2.87

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

222

1.76

2.83

1.7

1.5

ng/l

122.3

110.3

0.19

222

(3017704) Immunofixation for Urine

585

1.45

2.81

1.7

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1267

11570

1.10

2.79

1.7

1.6

—

(3016135) IgD [Mass/volume] in Serum

4.44

2.79

2.6

2.4

mg/l

339.5

123.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

408

3459

1.18

2.79

1.9

1.7

mg/l

3.3

3.4

0.11

314

2384

(3013762) Body weight Measured

3.22

2.76

1.0

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

346

1.59

2.76

1.4

pmol/l

14.9

16.1

0.75

288

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

142

1071

1.33

2.74

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

597

1.44

2.73

1.8

2.1

umol/l

13.7

30.9

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

131

1.98

2.73

1.1

ug/l

87.4

79.1

0.29

108

(40762887) Creatinine [Moles/volume] in Blood

5.00

2.72

1.4

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

160

1.87

2.69

1.5

—

(3000012) Reticulocyte production index

100

716

1.40

2.69

1.6

1.5

—

(4198724)

357

1.57

2.67

1.8

2.9

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

215

1720

1.25

2.65

1.3

1.4

—

(3009015) Lactate [Moles/volume] in Synovial fluid

119

2.02

2.64

1.3

1.2

mmol/l

6.2

6.4

0.10

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

126

940

1.34

2.63

1.3

nmol/l

1.6

1.4

0.80

109

837

(3003888) Timothy IgE Ab [Units/volume] in Serum

193

1527

1.27

2.62

1.1

u/ml

5.7

5.0

0.23

776

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.54

2.60

2.6

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

104

756

1.38

2.57

1.9

2.1

11.9

14.2

1.21

331

(3024263) Appearance of Synovial fluid

573

1.43

2.54

1.7

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

5.45

2.54

1.2

—

(3019174) dRVVT (LA screen)

2.22

2.52

1.1

1.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

363

1.54

2.50

1.3

mmol/l

3.6

3.3

0.26

329

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

511

1.45

2.45

1.1

u/l

1.0

1.1

0.96

244

(43055514) Macroprolactin [Presence] in Serum or Plasma

188

1.76

2.43

1.7

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

399

1.50

2.40

1.1

ng/l

1152.2

756.8

0.22

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

131

1.91

2.39

1.9

2.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

6.25

2.37

1.8

1.0

—

(3024471) HLA-A [Type]

305

1.57

2.36

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.63

2.36

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.61

2.35

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

139

1.87

2.35

1.5

1.2

u/l

206.6

535.9

0.41

100

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

111

1.98

2.34

1.1

u/ml

0.0

0.2

0.85

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

727

1.36

2.33

2.2

2.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

253

2095

1.21

2.30

1.5

1.8

nmol/l

0.9

0.8

0.89

201

1755

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

2.31

2.30

1.3

1.9

10.1

13.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

327

2772

1.18

2.30

1.3

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.18

2.30

1.1

u/l

6.3

13.6

1.17

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

268

1.60

2.30

1.2

1.1

—

(3020491) Glucose [Moles/volume] in Blood

108

807

1.34

2.28

1.7

2.0

mmol/l

7.2

6.9

0.32

575

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

292

1.58

2.28

1.1

—

(40762814) Titanium [Mass/volume] in Blood

207

1.69

2.28

2.5

2.2

ug/l

3.1

3.9

0.75

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

215

1.67

2.27

1.8

2.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.45

2.26

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.55

2.26

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.10

2.22

3.1

3.4

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

135

1.85

2.20

1.6

1.3

73.2

71.9

0.07

110

(3050794) Legionella sp Ab [Presence] in Serum

2.04

2.20

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

525

1.41

2.16

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

542

1.40

2.16

1.2

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

105

789

1.33

2.16

3.1

2.4

—

(3045716) Anion gap in Serum or Plasma

517

1.41

2.16

2.4

2.3

mmol/l

8.8

9.2

0.50

388

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

377

1.49

2.15

2.6

2.9

umol/l

31.1

28.2

1.06

280

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

180

1452

1.24

2.14

1.2

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

219

1.64

2.13

1.1

1.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

495

5598

0.88

2.13

1.5

1.4

—

(3044009) aPTT.lupus sensitive (LA screen)

2.10

2.11

1.1

1.3

—

(40768806) Pleura Pathology biopsy report

166

1329

1.25

2.11

1.5

1.6

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

275

1.56

2.09

1.4

1.3

42.3

35.3

0.56

182

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

102

1.96

2.09

1.4

1.2

ug/l

88.9

123.5

0.81

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.56

2.09

3.0

3.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

126

977

1.29

2.08

4.0

5.1

u/ml

240.0

108.2

0.71

302

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.90

2.06

1.2

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

207

1703

1.22

2.05

1.1

u/ml

1.1

1.3

0.26

669

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

710

1.34

2.04

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.98

2.04

1.0

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

4.00

2.03

1.0

1.1

titre

2388.3

2139.3

—

(3024869) Neuronal Ab [Presence] in Serum

199

1.66

2.03

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.00

1.99

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

248

1.57

1.96

1.2

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

771

8453

0.91

1.94

1.8

1.7

—

(3028717) Thiamine [Mass/volume] in Blood

1.94

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

313

1.50

1.93

1.3

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

281

1.53

1.93

1.6

1.3

14.2

21.8

1.70

233

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

330

1.48

1.91

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

371

1.46

1.91

1.6

2.9

—

(3029396) Erythrocyte agglutination [Presence] in Blood

180

1.67

1.90

2.5

2.7

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

582

1.36

1.89

1.1

ratio

1.1

0.03

205

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

397

1.44

1.88

1.3

1.2

umol/l

4.0

4.3

0.18

372

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

259

1.54

1.87

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

259

1.54

1.87

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

259

1.54

1.87

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

259

1.54

1.87

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

179

1470

1.22

1.84

1.1

u/ml

0.6

1.0

0.80

623

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

137

1.75

1.82

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

254

1.54

1.79

1.1

u/ml

1.2

6.1

0.79

138

(3036782) Glucose [Moles/volume] in Pleural fluid

140

1124

1.25

1.79

1.3

mmol/l

6.3

6.4

0.07

129

1029

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

239

1.55

1.77

1.1

—

(40758292) HTLV I+II Ab panel - Serum

161

1.68

1.77

1.3

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.93

1.74

1.3

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

113

889

1.27

1.73

1.3

1.2

—

(3045788) Cell count panel - Pleural fluid

142

1148

1.24

1.72

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

740

1.30

1.72

1.6

1.8

—

(3007463) Buprenorphine [Presence] in Urine

2.66

1.72

20.4

6.3

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.91

1.72

1.1

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.29

1.70

1.6

—

(3024932) HLA-DR beta [Type]

299

1.47

1.68

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

111

1.80

1.67

1.2

1.1

—

(3016750) Collection duration of Urine

656

1.31

1.67

2.1

min

511.0

499.0

0.62

468

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.16

1.66

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.93

1.63

2.0

3.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

112

1.78

1.63

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

3.57

1.61

6.4

6.6

mmol/l

0.1

0.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

237

1.52

1.61

7.6

7.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

165

1369

1.21

1.58

1.1

u/ml

2.0

1.9

0.03

325

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

321

1.43

1.56

1.7

1.8

—

(3002523) Influenza virus A Ag [Presence] in Specimen

165

1373

1.20

1.54

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.97

1.53

1.0

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.97

1.53

4.9

5.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

321

2821

1.14

1.52

2.3

2.4

ug/min

123.2

104.5

0.29

190

1661

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

545

1.32

1.50

1.2

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.85

1.50

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.85

1.50

6.0

8.9

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.90

1.48

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.94

1.48

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.94

1.48

1.0

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

410

1.37

1.46

1.5

1.9

—

(3003740) Influenza virus B Ag [Presence] in Specimen

164

1374

1.19

1.44

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

549

1.31

1.44

1.6

—

(3004775) Volume in Urine collected for unspecified duration

115

931

1.24

1.43

2.2

680.4

643.2

0.44

617

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

277

1.44

1.43

7.8

7.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

110

1.73

1.42

1.2

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

118

1.69

1.40

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

103

1.75

1.40

2.9

2.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.17

1.39

1.2

1.3

umol/24h

340.1

291.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

238

1.47

1.38

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

119

1.68

1.36

1.3

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.94

1.35

2.4

2.1

—

(3018291) Platelet Ab [Presence] in Serum

2.94

1.35

1.0

—

(3035880) pH of Pleural fluid

643

1.28

1.35

1.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

112

1.70

1.34

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.87

1.33

1.1

1.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

366

1.37

1.33

1.7

1.8

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

167

1.56

1.33

1.3

1.2

mmol/l

2.3

1.4

0.26

109

(3036048) Francisella tularensis Ab [Titer] in Serum

233

1.46

1.30

1.2

—

992.5

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.09

1.30

1.7

1.6

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

292

1.40

1.29

7.8

4.2

63.0

70.8

0.90

233

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.78

1.28

1.2

1.0

1.6

2.8

—

(3005011) Chlamydia sp Ab [Titer] in Serum

145

1.59

1.28

1.4

1.6

—

(3030313) Adrenal Ab [Titer] in Serum

1.88

1.28

1.1

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

114

1.67

1.27

1.2

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

138

1.59

1.25

1.1

1.5

nmol/l

0.1

0.2

0.75

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

146

1.57

1.25

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

162

1.54

1.24

1.0

1.3

—

(3026470) Cobalt [Mass/volume] in Blood

741

1.24

2.1

1.9

ug/l

3.2

3.9

0.45

654

(3016228) CD19 cells/100 cells in Blood

423

1.32

1.24

1.6

1.9

10.4

8.8

0.30

409

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

245

1.43

1.22

1.3

1.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.63

1.21

2.4

6.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

390

1.33

1.21

1.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

691

1.24

1.19

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

129

1082

1.19

1.18

1.1

u/ml

5.3

4.0

0.25

425

(3002619) Bacteria identified in Specimen by Culture

231

1.43

1.16

1.6

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

166

1.51

1.14

1.6

1.7

—

(3001729) Color of Synovial fluid

1.68

1.13

3.1

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

616

1.25

1.12

1.5

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

216

1.43

1.12

1.4

1.2

mmol/l

1.6

0.09

128

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

301

1.36

1.11

1.3

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

294

2633

1.12

1.11

4.3

3.3

mg/l

26.7

28.9

0.48

177

1692

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

432

1.30

1.10

1.0

1.1

93.4

94.7

0.10

333

(3013166) Neutrophils/100 leukocytes in Synovial fluid

337

1.33

1.08

2.0

1.4

55.8

57.4

0.12

287

(3025577) Chromium [Mass/volume] in Blood

728

1.22

1.07

2.1

2.0

ug/l

2.0

2.4

0.69

608

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

110

919

1.20

1.07

1.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

513

1.27

1.07

3.9

3.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.68

1.07

2.9

2.8

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

505

1.27

1.06

1.5

1.6

mmol/l

7.6

7.9

0.43

299

(3017817) Protein [Mass] in Urine collected for unspecified duration

117

985

1.19

1.05

2.7

2.4

—

0.4

—

(3029075) Extractable nuclear Ab panel - Serum

287

1.36

1.05

1.1

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

613

1.24

1.05

1.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

106

1.60

1.02

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

255

1.37

1.01

2.4

e6/l

226.0

691.7

0.79

132

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

171

1.46

1.01

3.2

2.9

—

(3025130) Human papilloma virus identified in Specimen

142

1224

1.16

0.98

1.9

1.7

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

187

0.59

0.97

1.3

1.4

7.0

11.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

729

1.21

0.96

1.1

mg/l

278.3

280.3

0.03

629

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

354

1.30

0.95

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

149

1.48

0.94

1.0

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.22

0.93

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

555

0.77

0.92

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.73

0.92

2.2

2.7

—

(3035933) Granulocytes/100 leukocytes in Blood

269

1.34

0.91

1.4

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

490

1.24

0.91

1.2

72.7

63.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

110

1.54

0.90

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.74

0.89

1.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

527

1.23

0.89

1.2

1.1

u/ml

1.3

2.4

0.40

169

(3008116) Ketones [Moles/volume] in Urine by Test strip

210

1.38

0.89

1.3

—

(3009677) Dengue virus Ab [Presence] in Serum

2.07

0.89

1.7

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

262

1.34

0.88

1.3

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

219

1.37

0.88

2.2

1.8

ug/l

2.6

2.3

0.15

119

(1617658) Protocol used for examination of sentinel lymph nodes

913

0.83

0.87

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.00

0.86

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

314

2871

1.09

0.85

1.4

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

145

1.45

0.84

3.8

5.8

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

336

1.28

0.82

3.3

2.2

nmol/l

162.6

151.3

0.37

288

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.55

0.80

1.8

1.7

mg/l

1.7

1.5

0.38

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

112

968

1.16

0.80

1.1

u/ml

0.2

0.4

0.54

215

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

147

1.43

0.79

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.82

0.79

1.0

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.82

0.79

1.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.67

0.78

1.0

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

757

1.18

0.78

1.1

mg/l

44.6

42.5

0.12

620

(3020650) Glucose [Presence] in Urine

260

1.31

0.77

2.1

1.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.76

0.0

1.0

—

(3022475) Manganese [Moles/volume] in Blood

1.69

0.75

1.5

1.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.67

0.74

1.0

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

158

1.39

0.73

1.1

1.4

35.3

52.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

132

1163

1.14

0.73

1.1

u/ml

4.5

4.1

0.10

446

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.84

0.73

1.0

1.1

mg/l

0.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.55

0.71

1.1

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

185

1.35

0.71

7.6

6.8

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.92

0.70

1.0

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.92

0.70

1.4

1.1

mmol/l

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

109

1.47

0.70

1.1

—

(3018133) Calcium [Moles/volume] in Urine

160

1.37

0.69

2.4

1.9

mmol/l

2.6

0.02

140

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

704

0.84

0.68

1.2

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

110

1.45

0.68

1.3

1.2

mmol/l

20.8

21.0

—

(3047189) Immunofixation for 24 hour Urine

528

1.19

0.67

2.3

1.7

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

441

0.79

0.67

1.3

1.4

69.4

65.3

0.33

366

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

140

1247

1.12

0.67

1.4

nmol/l

0.4

0.06

113

945

(40768793) Breast Pathology biopsy report

231

2514

0.92

0.66

1.3

—

(4212803)

103

1.46

0.64

1.2

1.0

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.72

0.63

1.0

—

0.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

448

0.80

0.63

1.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

146

1.37

0.63

1.3

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

369

1.22

0.61

1.2

1.1

—

(3015183) Erythrocyte sedimentation rate

442

1.20

0.61

1.8

1.2

—

(3001556) Androgen free Index in Serum or Plasma

1.55

0.61

1.7

1.2

—

(4133840)

261

1.26

0.61

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

351

1.22

0.61

1.7

1.8

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

105

1.43

0.59

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.71

0.57

2.8

3.6

—

(44806071)

123

1.38

0.57

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

123

1.38

0.57

1.5

1.6

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

183

0.71

0.55

1.0

mg/g

9.4

7.7

0.31

172

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

329

1.22

0.55

1.2

1.3

15.7

24.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

293

1.23

0.54

1.6

1.7

ug/l

10.2

8.7

1.20

293

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.41

0.53

1.8

2.7

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

151

1.32

0.53

1.6

1.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

524

1.16

0.53

1.1

u/ml

0.7

6.2

0.65

145

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.51

0.52

1.2

1.1

—

(4281824)

132

1197

1.10

0.51

1.3

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

235

0.76

0.49

3.4

6.7

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.52

0.48

1.0

1.1

nmol/l

209.6

247.5

—

(44806420)

355

1.18

0.46

2.0

2.5

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.43

0.46

1.1

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

141

0.71

0.44

1.0

2.9

mmol/l

6.7

7.8

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

349

1.17

0.42

1.3

ug/l

12.4

172.5

1.54

201

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

229

0.78

0.42

1.1

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.51

0.41

3.2

3.6

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.51

0.41

1.6

1.2

nmol/l

466.9

575.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.3

—

1.8

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

179

1917

0.93

0.41

3.4

3.6

u/ml

72.3

38.9

0.60

174

1851

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

841

1.11

0.41

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.31

0.39

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.43

0.39

1.0

1.1

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

10.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

125

1353

0.92

0.38

1.7

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

741

1.11

0.37

1.0

ng/l

757.1

700.3

0.53

491

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

703

1.11

0.37

5.9

6.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

213

2005

1.06

0.37

1.5

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

742

1.10

0.37

1.0

ng/l

37.5

44.4

1.11

500

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.28

0.36

7.9

8.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

244

1.19

0.36

1.4

1.3

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.43

0.35

6.0

9.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

688

1.10

0.35

1.4

1.3

pmol/l

41.5

111.4

0.95

217

(3037556) Urate [Mass/volume] in Serum or Plasma

349

1.15

0.33

1.7

1.5

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

191

1.20

0.33

2.8

5.7

u/l

35.2

69.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.28

0.32

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

168

1581

1.06

0.31

1.1

iu/ml

5551.1

824.5

0.41

368

(3011325) HIV 1+2 Ab [Presence] in Serum

1.34

0.31

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

100

0.70

0.30

1.4

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

618

1.10

0.30

1.5

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

567

0.90

0.30

1.9

2.2

ug/min

58.0

129.1

—

138

(40768795) Lymph node Pathology biopsy report

124

1159

1.07

0.29

1.3

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

195

0.82

0.29

1.0

1.1

—

(3011544) Albumin [Mass/volume] in Pleural fluid

103

1.26

0.28

1.0

1.2

g/l

20.0

17.0

0.74

(3039443) Prostate specific Ag panel - Serum or Plasma

167

1757

0.95

0.26

1.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

146

1380

1.06

0.26

1.2

1.3

mmol/l

7.4

7.6

0.26

105

976

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.22

0.25

1.2

1.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

742

1.08

0.25

1.0

ng/l

293.6

337.1

0.83

510

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

109

1156

0.94

0.24

1.3

1.5

—

(4038314)

1.25

0.22

1.2

1.3

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

146

0.82

0.22

1.0

1.1

u/ml

0.0

7.0

—

106

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

124

0.81

0.21

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.19

0.21

1.0

mmol/l

8.5

8.3

—

(4027681)

574

1.08

0.21

1.2

1.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.22

0.21

1.0

1.2

umol/24h

1.7

1.6

0.10

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.21

0.0

1.0

—

(3035060) Mercury [Moles/volume] in Blood

0.00

0.20

0.0

2.4

—

18.8

—

(3010937) Rubella virus Ab [Presence] in Serum

1.25

0.20

1.3

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

468

0.92

0.19

1.2

1.1

—

(40758358) Immune stain study

1.18

0.19

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

321

3121

1.03

0.18

1.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.17

0.17

1.0

1.1

—

(4034850)

375

3656

1.03

0.17

11.4

10.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

902

1.05

0.17

1.4

1.5

ug/l

3.4

4.9

1.08

769

(3022689) Creatine [Moles/volume] in Urine

320

1.09

0.16

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

145

1505

0.96

0.16

1.3

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

474

4643

1.02

0.16

1.8

1.7

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.08

0.14

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.18

0.14

1.3

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

117

0.85

0.13

1.9

2.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

461

1.06

0.13

2.7

2.2

umol/l

53.1

54.6

0.13

379

(3014891) Appearance of Pleural fluid

190

1.10

0.12

1.6

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

329

3226

1.02

0.11

1.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

178

0.90

0.11

3.1

2.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

178

0.90

0.11

6.1

5.8

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

404

0.94

0.11

1.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

464

0.95

0.10

1.1

1.0

u/ml

0.3

1.7

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

144

1.11

0.10

13.6

7.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

133

1365

0.97

0.10

1.5

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.09

0.09

1.4

1.1

—

(1761868) Lipid panel - Serum or Plasma

3771

37802

1.00

0.09

3.1

2.9

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

164

1604

1.02

0.08

1.5

1.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

113

0.88

0.08

1.4

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

164

1605

1.02

0.08

1.5

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

612

0.96

0.08

1.3

g/l

1.6

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.82

0.07

1.0

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.82

0.07

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

163

1598

1.02

0.07

1.5

1.4

—

(3017509) Phencyclidine [Presence] in Urine

1.07

0.07

1.4

1.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.06

0.07

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

176

1728

1.02

0.07

1.6

1.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

224

0.94

0.07

2.5

3.1

ng/l

136.3

106.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

197

1.06

0.06

1.1

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

218

1.05

0.05

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

162

1596

1.01

0.05

1.5

1.4

—

(3036603) Volume of Urine

725

0.98

0.04

1.7

1.6

1569.0

1955.8

1.63

176

(3027035) Albumin [Mass/time] in 24 hour Urine

102

1.08

0.03

1.6

1.3

—

616.9

—

(3000034) Microalbumin [Mass/volume] in Urine

109

1102

0.99

0.02

3.6

3.0

mg/l

50.2

53.9

0.06

803

(3005033) Fetal Nuchal fold Thickness US

133

1318

1.01

0.02

1.5

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

154

1.04

0.00

3.7

2.7

u/field

0.4

0.5

0.42

154

(3047352) Trisomy 18 risk [Likelihood] in Fetus

132

1324

1.00

0.00

1.5

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

124

0.97

0.00

1.1

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.1

—

314.3

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.92

0.00

1.4

1.1

—

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

0.00

0.0

1.0

—

177.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.95

0.00

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

0.98

0.00

1.0

—

-2.7

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.92

0.00

1.1

1.5

—

(3018487) Sunflower Seed IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.1

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.2

—

(3006598) pH of Arterial cord blood

0.98

0.00

1.0

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.3

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.0

1.1

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

0.91

0.00

1.0

1.1

—

(3017497) Pine Nut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.0

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

8.0

—

1.4

—

(3011829) Common Millet IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_OTHANRECT and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_OTHANRECT	1.483 [1.36, 1.62]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.159

During the follow-up period (1.1.1998 — 31.12.2019), 13064 out of 45745 females with K11_OTHANRECT died.

Males

Parameter	HR [95% CI]	p-value
K11_OTHANRECT	1.492 [1.36, 1.64]	< 0.001
Birth year	0.986 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 10602 out of 35708 males with K11_OTHANRECT died.

Mortality risk

Mortality risk for people of age

years, who have K11_OTHANRECT.

N-year risk	Females	Males
1	0.151%	0.238%
5	0.876%	1.744%
10	2.137%	4.233%
15	4.04%	7.725%
20	7.059%	13.225%

Relationships between endpoints

↥

Index endpoint: K11_OTHANRECT – Other diseases of anus and rectum

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other diseases of anus and rectum

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints